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Polyketides are a diverse class of natural products that have varying 
therapeutic values.  Polyketide synthases (PKSs) use different domains within 
the larger enzyme to vary the amount of reduction seen at each ketide position.  
The ability to manipulate PKSs would make the synthesis of unnatural 
polyketides possible, potentially creating novel biologically active molecules. 
 Bacillus subtilis strains 39320 and 39374 produce the polyketide antibiotic 
difficidin, which has a subunit that can not be explained by well-understood 
polyketide synthesis.  Studies of the synthesis of difficidin may be useful for 
diversifying the synthesis of new unnatural polyketides.  Sfp, a 
phosphopantetheinyl transferase (PPTase) activates ACPs.  AcpK carries an 
acyl unit to react with PksG, an enzyme that synthesizes an intermediate that 
may lead to the unusual subunit.  An enzyme expressed during sporulation, 
MmgA, is homologous to acetyl coenzyme A acetyltransferases.   
 AcpK, PksG, and MmgA were successfully cloned, overexpressed, and 
purified from B. subtilis strain 168.  Sfp was successfully cloned, overexpressed, 
and purified from a donated overexpression vector.  PPT reactions with Sfp and 
AcpK were successfully performed.  Biochemical characterization of PksG was 
carried out and defined by other unrelated research.  MmgA was biochemically 
determined to be a β-keto acyl thiolase. 
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CHAPTER I 
 
INTRODUCTION 
 
I.A Polyketide Structures and Biosynthesis 
 
Polyketides are a diverse class of natural products that can be produced 
by certain bacteria, fungi, plants, and animals.  These products have a variety of 
pharmacological applications.  Figure I-1 shows examples of polyketides that 
have therapeutic value including naphthomycin A an antibiotic, dynemycin A an 
anticancer compound, tetronasin an antiparasitic agent, rapamycin an 
immunosuppressant, streptazolin an antifungal, and mevinolin a cholesterol 
lowering compound (Rawlings, 1997).   
Figure I-1 Examples of polyketides having medicinal value (Rawlings,1997).
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Polyketides are assembled by enzymes called polyketide synthases 
(PKSs).  There are three types of PKSs, type I-III, and each assembles the 
product in different routes, though the chemistry is very similar.  Type I PKSs are 
arranged in modules that contain multifunctional enzymes which produce 
nonaromatic polyketides.  Type II PKSs are made up of a single set of proteins 
that are iteratively used to synthesize aromatic polyketides (Shen, 2003). 
 PKSs are comparable to fatty acid synthases (FASs) because the function 
of enzymes present in each synthase catalyzes similar reactions.  Type I FASs 
are also single, multifunctional, proteins (Hopwood, et al., 1990).  FASs initiate 
fatty acid chain synthesis by a decarboxylative condensation between an acetyl 
unit (C2 starter unit) and a malonyl unit (C3 extender unit) yielding a C4 product.  
The acetyl starter unit is transferred from acetyl coenzyme A (CoA) to a domain 
found in the FAS called the acyl carrier protein (ACP) domain.  This transfer is 
catalyzed by another domain, the acyltransferase (AT) domain. 
Decarboxylation occurs after the starter unit moves to the ketosynthase 
(KS) domain and a extender unit is attached to a newly opened ACP domain.  
The KS domain catalyzes the decarboxylation step that forms the C4, β-ketone 
product.  This β-ketone undergoes further reductions by other enzymes.  These 
enzymes are a ketoreductase (KR), which yields an alcohol in the β position, a 
dehydratase (DH), which yields a double bond, and an enoylreductase (ER), 
which yields a fully saturated methylene group.  Elongation occurs when a new 
extender unit is loaded and another round of condensation and subsequent 
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reductions occur, extending the chain by two carbons.  This elongation and 
reduction cycle continues until a specific chain length is reached.  The chain-
length is specified by a final domain, the thioesterase (TE), which hydrolyzes the 
ACP-thioester, breaking the free fatty acid (Katz, et al., 1993).  The initial 
condensation and sequential reduction reactions catalyzed by the different 
domains in the FAS can be seen in Figure I-2. 
 
Figure I- 2 Reactions in fatty acid synthesis. 
 
Polyketides are produced by a similar mechanism with four exceptions, 
the diversity of starter units used, a variable extent of reduction of each β-ketone 
unit, the introduction of chiral centers by either the β-hydroxyl group or side 
chains present, and post synthetic modifications such as cyclization, 
lactonization, and glycosylation, among others (Katz, et al., 1993).  These 
differences are greatly responsible for the diversity seen in polyketide natural 
products. 
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One of the most studied PKSs is from the organism Saccharopolyspora 
erythraea, the producer of erythromycin A, an antibiotic useful against Gram-
positive bacteria.  By the year 1965 the structure and stereochemistry of 
erythromycin A had been determined (see Figure I-3).  Erythromycin A is 
synthesized in two phases.  The first phase involves the PKS portion of the 
molecule, and the second is post polyketide synthase “tailoring” (Staunton, et al.,
1997). 
 
Figure I- 3 Structure of erythromycin A (Staunton et al., 1997). 
 
The polyketide portion of erythromycin A is synthesized using propionate 
as a starter unit and methylmalonate as extender units.  This process forms a 
precursor to erythromycin A called 6-deoxyerythronolide B (6-DEB).  The 
proteins that synthesize this molecule are called 6-DEB synthase (DEBSI-III) for 
this reason.  DEBSI-III each contains two modules that are responsible for the 
extension of the polyketide chain by two carbon units until after module 6, when 
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the TE releases the fully formed chain.  Each module contains the necessary 
domains, the AT, the ACP, and the KS.  Other reducing domains may be present 
which can include, KR, DH, and ER.  Each module extends the polyketide chain 
and reduces the β-ketone until the module-encoded functional group is obtained 
(Staunton, et al., 1997).  The last step catalyzed by DEBS is release by 
macrolactonization by the TE domain.  These modules can be seen in Figure I-4 
and the resulting structure of 6-DEB. 
 
Figure I- 4 DEBS I-III and the structure of 6-deoxyerythronolide B 
(Staunton, et al., 1997). 
 
I.B Combinatorial Biosynthesis 
 Polyketide synthesis occurs through common routes, though the products 
can be diverse.  The structures of polyketides can be correlated directly to the 
6
sequence of modules within their cognate modular PKS.  The number of 
modules, the choice of starter and extender unit, and the domains inside the 
modules are some of the ways this natural product diversity is explained 
(McDaniel, et al., 1999).   
 Research into the manipulation of the biosynthetic pathways of polyketide 
production has led to the engineered biosynthesis of “unnatural” natural products.  
With DEBS being one of the most well understood PKS, it has also been the 
subject of the first studies for this manipulation to yield these products.  One of 
these studies, conducted by McDaniel, et al., AT domains and different β-carbon 
processing domains from another organism were introduced into DEBS.  The 
combinations of these substitutions yielded polyketides that utilized different 
starter units and had variably reduced carbons at the ketide positions.  With the 
vast amount of experiments conducted a combinatorial library of over 60 analogs 
of 6-DEB were produced (McDaniel, et al., 1999). 
 Other experiments with DEBS involved movement of the TE domain to 
DEBS I or II, which lead to the expected shortened product, and hybridization of 
whole modules from other PKSs, leading to chimeric products (Staunton, et al.,
1997).  Strategies that either add or delete tailoring enzymes can also lead to 
increased diversity of polyketide products, and replacement of KR domains can 
change the stereochemistry of the alcohol (Staunton, et al., 1997). 
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I.C Difficidin 
Though the strain does not produce a polyketide, Bacillus subtilis strain 
168, a Gram-positive bacterium, contains a 15-gene operon that has six genes 
with sequence homology to PKSs.  The rest of the genes did not show any 
similarity to PKS genes (see Table I-1) (Kunst, et al., 1997). 
 
Table I-1 pksX cluster found in Bacillus subtilis strain 168. 
Gene Name Function Based on Homology 
pksA Transcriptional Regulator 
pksB Zn-dependant Hydrolase 
pksC-E Acyl Transferase (AT) 
acpK Acyl Carrier Protein (ACP) 
pksF Ketosynthase/ AT 
pksG Hydroxymethylglutaryl (HMG)-CoA Synthase 
pksH-I Enoyl CoA Dehydratases 
pksJ-R AT-Less Type I PKSs 
pksS Cytochrome P450 (hydroxylase) 
Bacillus subtilis strains 39320 and 39374 produce the broad spectrum 
antibiotic difficidin (Zweerink, et al., 1987).  Difficidin is of interest because it 
contains a subunit that cannot be explained by normal polyketide synthesis, 
being that the C3 position of difficidin has three carbons attached (see Figure I-
5). 
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Figure I- 5 Difficidin. 
 
Difficidin contains an external carbon-carbon double bond, instead of a 
usual polyketide subunit at the C3 position.  Usual polyketide subunits are a 
ketone, an alcohol, a double bond, or a methylene group all with two carbons 
bound to the central ketide carbon.  This branching subunit is an interesting 
system to study, and the results could potentially be used in combinatorial 
biosynthesis.  Our lab is interested in the formation of this branching ketide, and 
our hypothesis is that two possibilities could lead to this subunit.  The first 
hypothesis involves the attachment of a new type of precursor molecule that 
already contains the subunit.   
This would occur in the following steps.  PksC, an acyltransferase, 
charges AcpK with a malonyl group.  PksF decarboxylates the malonyl group to 
form acetyl-AcpK.  PksG then would condense acetyl-AcpK with acetoacetyl-
PksL, which would be contained on one of PksL’s thiolation domains, to produce 
an HMG-PksL intermediate.  PksH would then dehydrate the HMG intermediate, 
creating an unsaturated carbon-carbon double bond.  PksI would then 
decarboxylate this intermediate, leading to a nucleophilic attack on the nascent 
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polyketide chain contained on the second PksL thiolation domain.  This reaction 
would yield a difficidin precursor with an internal carbon-carbon double bond at 
the C2-C3 position.  To make difficidin, other PKSs within the operon would 
cyclize the open chain, and an isomerase would externalize the double bond at 
the C3 position.  This hypothesis can be seen in Figure I-6. 
 
Figure I- 6 First hypothesis for difficidin production. 
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The second hypothesis is that the polyketide chain is grown through 
typical polyketide chemistry, and the external carbon atom is added after the 
backbone is complete. This process would also begin by loading of a malonyl 
unit onto PksC, and decarboxylation by PksF.  In this hypothesis PksG would 
then condense acetyl-AcpK with a difficidin precursor molecule on PksL that 
contains a ketone at the C3 position.  This would then lead to an HMG-like 
intermediate.  PksH would then dehydrate the intermediate to produce an internal 
double bond at the C2-C3 position, and PksI would then decarboxylate.   
Two possibilities exist for how the branching double bond in difficidin 
would be formed from this point.  One possibility is that the enolate is protonated 
at the C2 position.  In this case the bond at the C3 position would maintain an 
external double bond, and PKSs can then cyclize the open chain to directly form 
difficidin.  The second possibility is after PksI decarboxylates, and the enolate is 
formed at the C1-C2 postion, the electron density goes into the branching double 
bond on the C3 position, causing a proton to be abstracted from a nearby acid.  
This leads to a fully formed difficidin chain with a carbon-carbon double bond at 
the C2-C3 position.  This difficidin precursor will then be cyclized by other PKSs 
and the double bond will be externalized by some isomerase.  The second 
hypothesis can be seen in Figure I-7. 
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Figure I-7 Second hypothesis for difficidin production. 
 
These two possibilities probably involve the proteins PksFGHI, and have 
been characterized by other workers (Calderone, et al., 2006).  The proteins 
PksFGHI found in B. subtilis 168 are not unique to this organism.  Other 
homologs of these proteins can be found in other species of bacteria that 
produce polyketides with branching subunits that contain three carbons instead 
of the usual two carbons.  Two specific examples of these polyketides are 
12
curacin A, and myxovirescin (Simunovic, et al., 2006; Gu, et al., 2006).  The 
genome of Lyngbya majuscula, the producer of curacin A, and the genome of 
Myxococcus xanthus, the producer of myxovirescin, contains genes that are 
homologs of to PksFGHI from B. subtilis 168.  These polyketides can be seen in 
Figure I-8 and the branching subunits are circled.  Curacin A and myxovirescin 
also have subunits in their structure that include an extra carbon.  Research has 
shown that the homologous genes of PksFGHI, contained in the two organisms, 
are involved in the synthesis of these subunits (Simunovic, et al., 2006; Gu, et 
al., 2006). 
 
Figure I- 8 Structures of myxovirescin and curacin A with branching ketide 
 positions circled (Simunovic, et al.; Gu, et al.). 
 
Though reactions catalyzed by PksFGHI have been observed, the 
question of how the unusual subunit is installed in the full biosynthesis has not 
been completely elucidated.  Research is still needed to determine if an unusual 
subunit is first synthesized by PksFGHI and then added to the backbone, or if the 
backbone is synthesized and acted on by PksFGHI after backbone synthesis.  
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The genome of B. subtilis shows that either hypothesis could be correct because 
there is another protein in the genome of B. subtilis 168, PksL, containing two 
thiolation domains.(Calderone, et al., 2006).  The two thiolation domains support 
the hypothesis that an unusual precursor could be synthesized and then loaded 
onto PksL which would contain the growing polyketide backbone, and then 
added to the backbone by other enzymes. 
I.B.1 Roles of AcpK and Sfp in polyketide biosynthesis 
 Type I PKSs are organized in modules that contain a minimum of a β-
ketoacyl synthase (KS), an acyltransferase (AT), and an acyl carrier protein 
(ACP).  ACPs are synthesized in an apo, inactive, form.  In order for the ACP to 
become active, its holo form, a phosphopantetheinyl prosthetic group from CoA 
is attached to a conserved serine residue in a post translational modification.  
This reaction is catalyzed by enzymes called phosphopantetheinyl transferases 
(PPTases) (Mootz, et al., 2001).  This reaction can be seen in Figure I-9. 
Figure I- 9 Phosphopantetheinylation reaction. 
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To initiate polyketide biosynthesis, an activated monomer is loaded onto 
the first holo-ACP.  During chain elongation, the chain is docked at an upstream 
ACP and undergoes nucleophilic attack initiated by the downstream KS domain 
on the downstream module.  This ensures the direction of chain transfer from the 
upstream ACP to the next downstream KS (Stein, 2005).  According to the 
auxiliary domains present in the module the chain is passed from active site to 
active site until the full module has been utilized.  The finished chain is then 
extended and processed by the next downstream module.  The genome of 
Bacillus subtilis strain 168 contains the pksX cluster (refer to Table I-1).  The 
gene acpK is part of this operon, and codes for a freestanding ACP (Kunst, et al.,
1997).  In B. subtilis the PPTase enzyme is called Sfp.  However, in strain 168 of 
this bacterium, Sfp is synthesized in an inactive form due to a frame shift 
mutation (Stein, 2005).   
In work by Nakano, et al., a sfp gene was cloned from Bacillus subtilis that 
codes for an active protein and in research done by Mootz, et al., Sfp was found 
to catalyze the phosphopantetheinylation reaction on AcpK (Nakano, et al., 1992; 
Mootz et al., 2001).  This research showed that Sfp will use CoA to 
phosphopantethinylate AcpK; however, it has been shown that Sfp can also 
catalyze the same reaction using different acyl CoAs.  This ability to make holo-
AcpK directly charged with acyl chains will be important to our studies of the 
synthesis of difficidin and bacillaene.  The products that are of interest are acetyl-
holo-AcpK, acetoacetyl-holo-AcpK, malonyl-holo-AcpK, and holo-AcpK.  Acetyl-
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AcpK will be important for functional studies using PksG, which will be discussed 
in more detail in the following section.  For this study overexpression and 
purification of AcpK, cloned from B. subtilis strain 168, and Sfp, from a plasmid 
donated to the lab from the Zuber group, will be necessary (Nakano, et al.,
1992).  Finally, the different phosphopantetheinylation reaction conditions will 
need to be optimized.  The information obtained from these reactions will be 
useful in later studies concerning the enzymology of polyketide biosynthesis in B. 
subtilis.
I.B.2 Function of PksG in difficidin production 
 Another research goal outlined in this thesis is the determination of the 
chemical function of PksG in difficidin synthesis.  There are two hypotheses 
concerning PksG, The first involves an acetoacetyl group, which is attached to 
one ACP domain on PksL, is reacted with acetyl-AcpK in the presence of PksG.  
This reaction produces an HMG-PksL precursor that would later be introduced 
into a previously synthesized difficidin chain (see Figure I-10).  Then through 
subsequent reactions difficidin will be synthesized with the exocyclic double 
bond. 
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Figure I- 10 PksG function in first hypothesis. 
 
The second hypothesis involves PksG acting on a fully formed difficidin 
chain on one ACP domain of PksL.  PksG would then condense the β-keto group 
with acetyl-AcpK to form an HMG-like intermediate on the longer polyketide chain 
(see Figure I-11).  Enzymes (PksHI) would then decarboxylate and dehydrate 
this intermediate to yield a mature difficidin molecule with the exocyclic double 
bond. 
 
Figure I- 11 PksG function in second hypothesis. 
 
This project aims to determine the activity of PksG from B. subtilis 168. In 
order to successfully carry out this study we will require data obtained from the 
above section concerning the optimized PPTase reactions with AcpK.  In studies 
performed by Calderone, et al. the characterization of PksCFGHI had been 
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successfully completed prior to this thesis.  This research conclusively showed 
that PksG can act as an HMG-PksL synthase (Calderone, et al., 2006).  This 
result, however, does rule out the second mechanism in Figure I-7. 
 
I.B.3 Functionality of MmgA 
 Bacillus subtilis has long been known to have the ability to sporulate.  This 
is a response to environmental stresses like starvation.  The end result is that 
one cell makes a daughter cell that eventually becomes an endospore, while the 
mother cell commits most of its resources to the sporulation process and at the 
end finally lyses releasing the spore.  This process can be divided into five 
phases, with four being under the control of specific sigma factors (Errington, et 
al., 1993).  One of these sigma factors, σE, is used in the intermediate stages of 
the sporulation process.  Bryan, et al. have uncovered an operon that is under 
control of a σE promoter which they called mother cell metabolic genes, the mmg 
operon (Bryan, et al., 1996).  This group reported that there were five genes in 
this operon, mmgABCDE, however the full genome sequence later showed that 
the operon contains one additional gene under the same control, called yqiQ,
which could potentially be renamed mmgF (Subtilist Web Server, accessed 
March 12, 2007). 
 The gene mmgA shows acetyl CoA acetyltransferase homology (Bryan, et 
al., 1996).  This type of enzyme catalyzes the condensation of two acetyl CoA 
units to produce one acetoacetyl CoA unit and a CoA unit.  Conversely these 
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enzymes have been able to catalyze the reverse reaction; the thiolysis of one 
acetoacetyl CoA, by CoA, to yield two equivalents of acetyl CoA (see Figure I-
12). 
 
Figure I- 12 Proposed MmgA reaction. 
 
Having an enzyme that has this functionality would be helpful for 
experiments concerning the specific substrate for PksG in polyketide 
biosynthesis.  There have been two hypotheses proposed, and since there is no 
direct way to determine which hypothesis of difficidin production is correct, 
another study will be used.  This study requires a PksG- mutant of B. subtilis 
strain 39374, the producer of difficidin (Zweerink, et al., 1987).  PksG, a 3-
hydroxy-3-methylglutaryl (HMG) synthase, acts on either the acetoacetyl group 
attached to one ACP domain on PksL, or on the long chain difficidin precursor 
molecule.  PksG is an important step in the synthesis of difficidin and by 
removing this enzyme from the in vivo difficidin synthesis process it is possible to 
reveal its role in polyketide biosynthesis by showing new metabolism or 
demonstrate natural requirements caused by the mutation.  Because a PksG-
mutant would not be able to create the HMG intermediate, a labeled replacement 
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substrate, 13C labeled 3-hydroxy-3-methylglutaryl-N-acetylcysteamine (HMG-
SNAC), will be introduced to a culture of PksG- B. subtilis 39374.   
MmgA could be used in a synthesis process to make 13C labeled 3-
hydroxy-3-methylglutaryl-N-acetylcysteamine (HMG-SNAC), as this compound is 
not available commercially.  The synthesis of HMG-SNAC would occur in the 
following steps.  First, labeled pyruvate will be reacted with CoA and NAD+ to 
produce labeled acetyl CoA, in a reaction catalyzed by commercially available 
pyruvate dehydrogenase.  MmgA would then be used with two labeled acetyl 
CoA units to produce labeled acetoacetyl CoA.  Labeled HMG-CoA will be 
produced by a HMG-CoA synthase from Staphylococcus aureus using labeled 
acetoacetyl CoA and labeled acetyl CoA (Campobasso, et al., 2004).  Finally, 
HMG-CoA will be reacted with SNAC to make labeled HMG-SNAC (see Figure I-
13). 
 
Figure I- 13 Synthesis of labeled 3-hydroxy-3-methylglutaryl-N-acetylcysteamine. 
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If the first hypothesis is correct, the culture will then directly use the  
labeled HMG-SNAC, and produce a labeled difficidin product, which can be 
detected using mass spectral analysis.  If the second hypothesis is correct, the 
culture will not be able to use this labeled substrate and we can instead expect a 
new difficidin derivative having a ketone group at the C3 position.  This project 
has two goals, the first aims to clone, overexpress, purify, and biochemically 
characterize the enzyme MmgA, and the second is to use MmgA in reactions for 
the synthesis of labeled substrates.
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CHAPTER II 
OVEREXPRESSION, PURIFICATION, AND REACTIONS INVOLVING ACPK, 
SFP, AND PKSG 
 
II.A Introduction to AcpK and Sfp 
In polyketide biosynthesis, acyl carrier proteins (ACPs) carry carboxylic 
acid building blocks and incomplete polyketide chains that, through Claisen 
condensations, result in the synthesis of a ketide chain.  These acyl chains are 
attached to the ACPs on the terminal thiol of a phosphopantetheine prosthetic 
group which is attached to a conserved serine residue.  ACPs are not 
synthesized with the phosphopantetheinyl (PPT) moiety attached, so post 
translational modification is necessary to convert the ACP from its inactive apo 
form to the active holo form.  A second enzyme is needed to carry this 
conversion out.  Phosphopantetheinyltransferases (PPTases) catalyze the 
transfer of PPT from Coenzyme A to a specific serine residue of the ACP (Lai,et 
al., 2006).  This general reaction can be seen in Figure II-1.   
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Figure II- 1 Phosphopantetheinyltransferase Reaction. 
 
The protein AcpK (acyl carrier protein K) is encoded by the genome of B. 
subtilis strain 168 and is part of the pksX cluster.  Like all ACPs, AcpK also 
requires a post translational modification to make an active (holo) protein.  In 
studies by Mootz, et al., AcpK had been reacted with Coenzyme A (CoA) in the 
presence of a known PPTase, Sfp (Mootz, et al., 2001).  Sfp is found in the 
genome of B. subtilis, and is necessary for the production of the antibiotic 
surfactin.  Sfp stands for surfactin production, which was a genotypic designation 
given to the B. subtilis strains that were known to produce surfactin and a sfpo
genotype was given to surfactin non-producing strains.  The gene sfp was known 
to be important to the production of surfactin when it was originally studied by 
Nakano, et al., though the function was not yet determined (Nakano, et al. 1992).  
Later, when this function was elucidated, the gene kept its original designation.  
The function of Sfp is to phosphopantetheinylate seven PCP (peptidyl carrier 
protein) domains in three subunits of the surfactin synthase (SrfABC).  This 
protein is also of particular interest because it is able to phosphopantetheinylate 
PCPs and ACPs domains from other organisms, including Saccharomyces 
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cerevisiae and Escherichia coli, making it a broadly specific protein (Quadri, et 
al., 1998). 
In the studies by Mootz, et al., Sfp was found to be able to charge the 
phosphopantetheinyl moiety from CoA to AcpK in the presence of Mg2+. (Mootz, 
et al., 2001)  The literature indicates that Sfp is not only capable of putting the 
usual phosphopantetheinyl chain from CoA on ACPs, but also has broad 
substrate specificity and can charge ACPs with the phosphopantetheinyl moiety 
of CoAs that have different acyl groups attached to the terminal thiol.  This ability 
to directly synthesize R-holo-AcpK proteins from apo-AcpK and R-CoAs will be 
helpful in the studies of understanding the biosynthesis of difficidin.   
 Difficidin is produced by B. subtilis strains 39320 and 39374. (Zweerink, et 
al., 1987) In normal polyketide chemistry the ketide chain is extended two 
carbons at a time.  Difficidin has an unusual subunit at C3, an exocyclic double 
bond that can not be explained by normal polyketide chemistry (see Figure II-2).  
The synthesis of this subunit likely involves homologs of the enzymes PksFGHI, 
though the sequence in which this happens is still unknown.  
 
Figure II- 2 Difficidin. 
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Two hypotheses have been proposed about the synthesis of this subunit 
in difficidin.  The first (Figure II-3) involves the synthesis of an unusual precursor 
that is incorporated in the difficidin molecule by the polyketide synthases.  The 
other hypothesis (Figure II-4) uses standard polyketide chemistry that generates 
a difficidin precursor containing a ketone at the C3 position.  Other enzymes 
(PksFGHI) would then act on this precursor, using acetyl-AcpK as the source of 
the third carbon to form difficidin. 
 
Figure II- 3 First hypothesis of difficidin production. 
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Figure II- 4 Second hypothesis for difficidin production. 
 
PksC, an acyltranferase, uses malonyl-CoA to produce malonyl-AcpK.  
This is then decarboxylated by PksF to make acetyl-AcpK.  PksG uses acetyl-
AcpK and PksL with either an acetoacetyl group on one of its thiolation domains, 
or the ketone with the difficidin precursor to produce a HMG subunit.  This then 
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undergoes a dehydration and decarboxylation by PksH and PksI, respectively. 
Finally, standard polyketide chemistry is used to produce the difficidin product. 
 
II.B Introduction to PksG 
 PksG from B. subtilis strain 168 has been studied by Calderone, et al. and 
has found that it catalyzes a reaction similar to HMG-CoA synthases. (Calderone, 
et al., 2006)  PksFGHI are responsible for synthesizing the unusual subunit found 
in bacillaene (see Figure- 5) (Butcher, et al., 2007).  Homologs of PksFGHI in B. 
subtilis 39374 and 39320 may be responsible for the branching subunit found in 
difficidin.  These genes are also contained in the genome for B. 
amyloliquefaciens this species has been known to synthesize difficidin (Chen, et 
al., 2006).  These genes, PksFGHI, are not unique to the genome of B. subtilis 
since homologs are found in the genomes of other organisms such as 
Myxococcus xanthus and Lyngbya majuscula. Myxococcus xanthus and 
Lyngbya majuscula produce myxovirescin and curacin A, respectively (see 
Figure II-6) (Simunovic, et al., 2006; Gu, et al., 2006).  These polyketides have 
branching polyketides similar to the one at C3 in difficidin.  In the research done 
on the synthesis of myxovirescin, the PksFGHI homologs TaKC/FXY from M. 
xanthus, are likely responsible for synthesizing the unusual subunits found in the 
final polyketide in a similar pathway proposed for the B. subtilis pksX enzymes 
(Simunovic, et al., 2006).  M. xanthus has two locations that have a third carbon 
on the ketide position, and the genome also has two homologs of PksG, called 
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TaC and TaF, that lead to an HMG intermediate.  L. majuscula also has 
homologs to PksFGHI called CurCDEF that leads to the synthesis of the 
cyclopropane substituent (Gu, et al., 2006).   
 
Figure II- 5 Bacillaene, with branching subunit circled. 
 
Figure II-6 Structure of myxovirescin and curacin A  
(Simunovic, et al., 2006; Gu, et al., 2006). 
 
Though the enzymatic activity of PksG from B. subtilis 168 has been 
measured, the timing of its involvement in the overall polyketide biosynthesis is 
still in question.  Studies on the substrate specificity of PksG can help elucidate 
the order of steps in this biosynthesis.  In the two hypotheses, PksG is proposed 
to react with substrates of vastly different length; a 4 carbon acetoacetyl chain in 
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hypothesis 1, or a 27 carbon chain in hypothesis 2.  In order to study the 
substrate specificity of PksG, β-keto acyl chains of varying length can be 
synthesized and loaded onto PksL by Sfp.  PksG in the presence of acetyl-AcpK 
can then react with these different length chains to form the HMG-PksL product 
(see Figure II-7 for reaction scheme). 
Figure II- 7 Reaction of PksG with β-keto acyl PksL Chains in the Presence of  
Acetyl-AcpK. 
 
Both the rates of the reactions with different substrates and mass spectral 
analysis of the products can help elucidate the substrate specificity of PksG.  The 
rates of reaction for each β-keto acyl-PksL can be compared.  Higher reaction 
rates with shorter β-keto acyl chains would show that PksG has a preference for 
smaller substrates, thereby supporting hypothesis 1.  Hypothesis 2 would be 
supported if PksG had a preference for longer chained substrates.  In order to 
conduct these studies, we require purified PksG, PksL, and AcpK.  Longer β-keto 
acyl chains would have to be synthesized, since they are not commercially 
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available, and these chains would have to be loaded onto the PksL protein.  
Acetyl-AcpK would also have to be produced using acetyl-CoA and Sfp as 
outlined in the studies of AcpK found in II.D.4.a.   
 Other studies involving PksG would still use the standard reaction seen in 
Figure II-7, but another enzyme will be used to produce 13C-labeled long β-keto 
acyl chains.  An acetyl-CoA acetyltranferase can be used to react labeled acetyl-
CoA derivatives to make the desired product.  These labeled chains would then 
be loaded onto PksL and, of a mixture containing all the different chain length 
reactants, reacted with PksG in the presence of excess labeled acetyl-AcpK.  
The product abundance can be determined my mass spectral analysis.  
Hypothesis 1 would be supported if the most abundant products formed were 
from the shorter β-keto acyl chains to produce a shorter chain HMG product.  
Conversely, hypothesis 2 would be supported if the most abundant products 
were formed from the longer β-keto acyl chains to form a longer chain HMG 
product. 
 
II.C Production and Characterization of AcpK, Sfp, and PksG 
II.C.1 Goals for the Production and Purification of AcpK 
 In order to test any hypothesis for difficidin production, we require pure 
holo-AcpK from B. subtilis 168, and also pure Sfp.  AcpK had successfully been 
cloned into pQE-60 by Mootz, et al. Since this research showed the pQE system 
yielded a pure protein in high amounts, our goal was to also clone into this same 
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system using pQE-60 (Mootz, et al., 2001).  Overexpression using pQE plasmids 
involves the strong T5 promoter on the plasmid and T5 RNA polymerase in the 
host.  The plasmid pQE-60 contains a T5 promoter sequence and two lac 
operator sequences for increased lac repressor binding.  The LacI repressor 
protein is encoded by a trans plasmid, pREP4, which controls the overexpression 
of the target protein.  Induction of the protein is started by disengaging the LacI 
protein from the lac repressor by addition of isopropyl-β-D-thiogalactopyranoside 
(IPTG), an artificial inducer of the lac operon.  Once IPTG is added, the cell 
commits nearly all of its resources to produce the gene under control of the T5 
promoter (The Qiaexpressionist, 5th ed.).  This is referred to as “overexpressing” 
the protein.  Here the gene under the control of the T5 promoter is acpK. This 
gene would be cloned into pQE-60 using a restriction digest of both pQE-60 and 
PCR-purified acpK, and a ligation would be performed using T4 DNA ligase.  
This cloned plasmid, pQE-60/acpK, would then be transformed into competent E. 
coli cells that contain the plasmid pREP4.  Overexpression would then be 
achieved by growing a culture of cells to mid-log phase and adding the inducer, 
IPTG.   
The second goal would be purification of the overexpressed protein.  
Because pQE-60 offers the option of including a C-terminal 6x histidine tag, 
affinity chromatography will be used to purify recombinant His-tagged AcpK.  For 
affinity chromatography we will use nitrilotriacetic acid (NTA) as a Ni2+ chelating 
adsorbent.  When a Ni-NTA column is used there are two vacant sites on the Ni2+ 
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that can bind the imidazole nitrogens present in the His6-tagged protein (see 
Figure II-8).  Low concentrations of imidazole will remove proteins that have 
histidine residues, but not a His6-tag, from the column.  A final, optimal 
concentration of imidazole would be used to elute the pure AcpK from the 
column.  The final step would be the enzymatic modification of AcpK by a 
phosphopantetheinylation reaction with CoA substrates containing different acyl 
chains.  These reactions will be analyzed by Electrospray Ionization Mass 
Spectroscopy (ESI-MS) and Matrix Assisted Laser Desorption/ Ionization Time-
of-Flight Mass Spectroscopy (MALDI-TOF-MS). 
 
Figure II- 8  Nitrilotriacetic acid chelated to nickel and associated with two   
histadine sidechains of a protein (The Qiaexpressionist, 5th ed.). 
 
II.C.2 Goals for the Production and Purification of Sfp 
 In order to perform the phosphopantetheine transfer reaction, large 
amounts of pure Sfp would be needed.  During the development of the work for 
this thesis, two methods were used to obtain purified Sfp.  Sfp had been 
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previously cloned into the overexpression vector pUC8 by Nakano, et al., and 
this vector was obtained as a gift from the Zuber group. (Nakano, et al., 1992)  In 
our first procedure we used this pUC8 system for this enzyme by modifications of 
the method of Nakano, et al. (Nakano, et al., 1992).  This method involved 
introducing the pUC8-sfp vector into competent E. coli MV1190 cells, a system 
which automatically overexpressed Sfp without the need for chemical induction.  
After the cells had grown overnight, ammonium sulfate precipitation was used to 
purify Sfp.   
 Because the first method of purification of Sfp did not yield a highly pure 
product, a second method was used.  To improve the efficiency and yield of Sfp 
we decided to clone Sfp into a His-tag system.  The vector chosen was pET-28a, 
a vector that places the gene of interest under the control of the T7 promoter.  
This promoter is under control of the lacI gene, which produces the LacI 
repressor protein (pET System Manual, 11th ed.).  After addition of the inducer 
IPTG, the cell then overexpresses the target Sfp protein. 
 To clone the sfp gene into pET-28a, a PCR of the pUC8/sfp plasmid would 
have to be performed, and a restriction digest is required of the pET-28a vector, 
and the similarly digested sfp PCR product.  This product is then ligated into the 
plasmid by T4 DNA ligase, and transformed into competent E. coli cells.  
Overexpression is performed by growing a culture of cells to mid-log phase, and 
induction with IPTG.  Purification would then be performed by Ni-NTA affinity 
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chromatography.  Sfp would then be used with purified AcpK in 
phosphopantetheinylation reactions.   
 
II.C.3 Goals for the Production and Purification of pBAD/pksG 
 To test our hypotheses for PksG activity it was necessary to have a large 
amount of pure PksG.  To accomplish this, PksG will need to be cloned into an 
overexpression vector, overexpressed in culture, and finally purified.  In prior 
work done by another graduate student, Kevin Williams, attempts at cloning 
PksG into the pET-28a overexpression system were not successful.  For this 
reason it was thought that PksG is toxic to E. coli. Because of this hypothesis, it 
was determined pksG needed to be placed under a more tightly regulated 
expression system, so the pBAD system was chosen for this reason.  
The pBAD system uses the araBAD promoter, which more tightly 
regulates the expression of the target protein.  The protein AraC creates a DNA 
loop that prevents transcription.  Arabinose binds to the AraC protein and 
releases the DNA loop that stopped the transcription from occurring, thus making 
arabinose the “inducer” for overexpression of the target PksG protein (Guzman, 
et al., 1995).  The pBAD system was used, though in later studies done by 
Calderon, et al. PksG was cloned and overexpressed using the pET system, 
showing that PksG is not a toxic protein (Calderone, et al., 2006). 
Once pksG is in an overexpression vector, it is possible to obtain large 
amounts of the protein.  To do this a culture of cells will be grown to mid-log 
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phase and induced using arabinose.  To purify PksG, a Ni-NTA column will be 
used because the protein was cloned in frame with a C-terminal His6-Tag coded 
by the plasmid.  The purified protein will then be used for activity assays with the 
enzyme’s suspected substrates.   
 
II.D Results 
II.D.1.a Cloning of pQE-60/acpK 
To clone acpK into pQE-60, primers were designed for polymerase chain 
reaction (PCR).  Using B. subtilis strain 168 as the template DNA and Vent 
polymerase, a PCR reaction was performed with 60 oC as the annealing 
temperature.  The gene length of acpK is 246 base pairs (bp).  The PCR reaction 
was determined to be successful because a band appeared on an agarose gel 
between 200-300 bp.  Once acpK had been successfully amplified, a restriction 
digest was performed on both the PCR product and the pQE-60 plasmid.  The 
restriction enzymes used for the digest of the PCR product was NcoI and BglII,
while the plasmid was digested with BamHI and NcoI. BglII and BamHI leave the 
same overhang when it cleaves DNA, which made it possible to still ligate the 
two fragments together using T4 DNA ligase.  Multiple ligation mixtures were 
used that contained different ratios of insert to vector, and the ligation reaction 
mixtures were transformed into competent DH5α cells.  The cells were then 
plated on ampicillin plates and incubated overnight at 37oC.  The following day 
ten transformants were chosen to inoculate ten starter cultures that were grown 
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overnight in 5mL of Luria Bertani (LB) media containing 25µg/mL of ampicillin.  
The cultures were shaken overnight at 37oC, and all plasmids were purified the 
following morning except for one culture which did not grow. 
 
II.D.1.b Gel Electrophoresis 
 To test for insert acceptance into all nine purified plasmids, nine PCR 
reactions.  The primers used were from the PCR amplification of acpK from B. 
subtilis strain 168.  The appearance of a band with the same number of base 
pairs as acpK, ~250 base pairs (bp), on an agarose gel would indicate a 
successful ligation.  A gel showed five out of nine plasmids contained the desired 
gene in the pQE-60 vector. 
 
II.D.1.c  Retransformation and Re-purification of pQE-60/acpK 
Once the cloning step was completed successfully, one cloned vector was 
chosen to be transformed into competent E. coli strain M15[pREP4] cells.  The 
cells were then grown at 37oC containing kanamycin and ampicillin.  Kanamycin 
and ampicillin selection was used because the pQE-60 plasmid confers ampicillin 
resistance, while the pREP4 vector confers kanamycin resistance, so it is 
possible to have a culture of cells replicating the two plasmids. 
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II.D.1.d  Overexpression and Purification of pQE-60/acpK 
 The target gene, acpK, had been successfully cloned in frame with a C-
terminal His-tag coded by the plasmid pQE-60.  The next step was to 
overexpress the protein using the cloned plasmid.  The strain pQE-60/acpK was 
grown in LB media containing 25µg/mL of ampicillin and 30µg/mL of kanamycin 
in a 37 oC shaker until mid-log phase was reached.  The culture was then 
induced and allowed to overexpress for three hours and the cells were 
harvested.  Once harvested the cells were resuspended and lysed to extract the 
protein from inside the cell and put it in solution. 
 Once the protein was in solution, the crude extract was applied to a Ni-
NTA affinity column and various concentrations of imidazole were used to wash 
proteins lacking His-tags from the column, and an optimal concentration was 
used to elute AcpK.  The eluted protein was then dialyzed overnight to remove 
excess imidazole and salt.  The following day the dialyzed protein was 
concentrated by centrifugation using a Vivaspin 5000 Molecular Weight Cut Off 
(MWCO) concentrator.  The protein was stored at -80oC with 10% glycerol.  An 
SDS-PAGE (Sodium Dodecyl Sulfate PolyAcrilamide Gel Electrophoresis) was 
performed on the crude AcpK extract, eluents from the various imidazole 
washes, the eluted protein, and the concentrated protein.  This SDS-PAGE can 
be seen in Figure II-9 which shows a bright band below the 14.4 kilodalton (kDa) 
molecular weight marker.  The expected mass of AcpK is 10561 Daltons and 
would be expected to migrate below the lowest molecular weight marker. 
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Figure II-9 SDS-PAGE of AcpK column chromatography purification. 
 
II.D.1.d  Protein Concentration Determination 
 The concentration of AcpK was determined by the Bradford method using 
Bovine Serum Albumin (BSA) as the standard.  BSA is available commercially at 
a concentration of 2.0mg/mL, and a standard curve was generated by varying the 
concentrations of albumin.  The average amount of AcpK obtained from a 1L 
culture was ~900µg. 
 
II.D.2.a  Overexpression and Purification of Sfp by a Previously Published  
 Method 
 In previously published work, the overexpression and purification 
procedures for Sfp had been studied and optimized by Nakano, et al. (Nakano, et 
al., 1992). Their procedure was followed to overexpress and purify the Sfp 
enzyme with the one exception of not using a DEAE column chromatography 
step after ammonium sulfate precipitation.  An overexpression vector that already 
contained the sfp gene, pUC8/sfp, was donated to the lab.  This vector was 
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transformed into competent MV1190 E. coli cells, and were grown overnight on 
plates that contained 25µg/mL of ampicillin.  To overexpress Sfp, a culture of 
cells was grown overnight and harvested the next day.  After a sonication step 
the protein was ready to be purified. 
To purify the Sfp enzyme, ammonium sulfate precipitation was used.  Four 
different percent concentrations of ammonium sulfate were used: 35%, 50%, 
65%, and 80%.  The final ammonium sulfate concentration precipitated the Sfp 
protein.  After centrifuging the 80% solution, the supernatant was discarded, and 
the pellet was retained.  This pellet was resuspended in buffer (20 mM Tris.HCl, 
pH 8.0) and dialyzed overnight in the same buffer the pellet was resuspended in.  
The enzyme was concentrated the next day, and glycerol was added to the 
concentrated protein at 10% concentration for -80 oC storage. 
 
II.D.2.b  Cloning of pET-28a/ sfp 
 To clone the sfp gene into pET-28a, a PCR was performed using the 
pUC8/sfp plasmid as the template.  Primers incorporated restriction sites for NcoI 
and XhoI, upsteam and downstream of the insert, respectively.  The PCR 
analyzed by agarose gel electrophoresis showed two bands on the gel, one at 
the correct size for sfp and one having a smaller size.  The correctly sized PCR 
product was purified by low melting agarose gel electrophoresis with the 
extraction of the band having the correct size.  To clone the amplified gene into 
pET-28a, a restriction digest was performed using NcoI and XhoI on both the 
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correctly sized PCR product and the pET-28a plasmid.  DNA ligase was used to 
ligate the restriction digested plasmid and PCR product together.  Multiple 
ligation reactions were performed that contained different insert to plasmid ratios. 
 The ligation reactions were transformed into competent E. coli DH5α cells 
and plated.  After incubation overnight, only two transformants had grown.  
These transformants were inoculated into a starter culture of LB containing 
30µg/mL of kanamycin.  The cultures were allowed to shake overnight at 37 oC.  
The following day the plasmids were purified.  To test for insert acceptance into 
the pET-28a plasmid, a second PCR was performed using Vent polymerase and 
the purified plasmids as the template DNA.  Agarose gel electrophoresis 
confirmed both plasmids contained the sfp gene.  Once the cloning of sfp into 
pET-28a was successful, one vector was chosen to be transformed into 
competent E. coli BL21(DE3) cells.   
 
II.D.2.c Overexpression and Purification of pET-28a/sfp 
The gene, sfp, had been successfully cloned in frame with a C-terminal 
His-tag coded for by the plasmid pET-28a.  The next step was overexpression of 
the protein.  Using the pET-28a/sfp overexpression strain, a culture of cells was 
grown in LB media containing 30µg of kanamycin per mL of culture.  The culture 
was shaken at 37 oC until mid-log phase was reached, at which time the culture 
was induced and grown for three hours.  The cells were then harvested, 
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resuspended, and sonicated.  After a final centrifugation step, the protein was 
purified by Ni-NTA chromatography. 
 To purify the enzyme the crude extract was applied to an Ni-NTA column.  
Various concentrations of imidazole were used to was nonHis-tagged proteins 
from the column, and an optimal concentration was used to elute Sfp.  The eluted 
protein was then dialyzed overnight.  The following day the dialyzed protein was 
concentrated by centrifugation.  The concentration was then determined using 
the Bradford method.  The average amount of Sfp obtained was ~1125µg per 1L 
of culture.  To be sure the correct protein was overexpressed, the various 
washes from the Ni-NTA column, and the concentrated, dialyzed eluent were 
analyzed by SDS-PAGE.  The gel showed a band at the expected mass of Sfp 
(~28 kDa), so it was determined the overexpression/purification was successful.  
Sfp was then ready to undergo reactions with AcpK and different acyl CoAs. 
 
II.D.3 Cloning, Overexpression and Purification of PksG 
 The gene pksG from B. subtilis strain 168 had been cloned and inserted 
into the pBAD overexpression plasmid by a former lab colleague, Kevin Williams.  
This plasmid was retransformed into the E. coli TOP10 strain and were plated 
and incubated for 37oC overnight.  To overexpress PksG, a culture was started 
which contained 25µg/mL ampicillin, and was allowed to grow until mid-log 
phase.  The culture was then induced with 0.01 M arabinose.  Growth was 
continued for three hours after which the cells were harvested by centrifugation. 
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The pellet was resuspended and 200µL of protease inhibitor was added, 
and the suspension was then sonicated to lyse the cells.  The protocols for the 
cloning, overexpression, and resuspention of PksG were provided by Kevin 
Williams.  After sonication and centrifugation the supernatant was then applied to 
an Ni-NTA column to purify the PksG protein.  Different concentrations of 
imidazole were used to elute nonHis-tagged proteins from the column, and a final 
concentration of imidazole was used to elute PksG from the column.  The eluate 
was dialyzed in buffer overnight and the following morning the diasylate was 
concentrated until the volume was between 500µL-750µL.  Bradford reagent was 
used to determine the concentration of the concentrated PksG.  To the 
concentrated PksG enough glycerol was added for a final 10% concentration, 
and the protein was stored at -80 oC. 
 
II.D.4.a Testing AcpK and Sfp Activity 
 AcpK is synthesized in the apo, inactive, form.  The protein Sfp is a 4’-
phosphopantetheine transferase (PPTase).  In order to be functional, the holo 
form requires a phosphopantetheine appendage on a conserved serine residue.  
The function of Sfp is to transfer the 4’-phosphopantetheine moiety of coenzyme 
A (CoA) to the serine residue of ACPs and PCPs making the holo, active, forms 
of these proteins.  The literature also indicates that Sfp can also transfer 
phosphopantetheine thioesters from a wide range of acyl CoAs as well. 
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In order to study the pks proteins, we were interested in exploiting this 
broad CoA and acyl CoA substance tolerance.  The specific CoAs tested were; 
CoA, acetyl CoA, acetoacetyl CoA, and malonyl CoA.  These expected AcpK 
modifications were analyzed by Electrospray Ionization Mass Spectral (ESI-MS) 
analysis and Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass 
Spectrometry (MALDI/TOF-MS).  These methods were also used to confirm the 
molecular weight of apo-AcpK from the overexpression previously performed.  
The expected masses of all the CoA’s can be seen in Table II-1. 
 
Table II- 1Theoretical mass of whole AcpK proteins. 
Before the phosphopantetheinyl reactions were carried out the mass of 
the apo-AcpK protein was analyzed by ESI-MS.  The spectrum obtained from this 
experiment can be seen in Figure II-10.  The molecular weight obtained, 10577 
Da, is consistent with the mass of apo-AcpK+16 Da.  Multiple experiments have 
also shown the correct mass of apo-AcpK, and also other variations observed 
during experimental assays.   
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The phosphopantetheinyl reactions were prepared that contained Sfp, 
AcpK, acyl CoAs, and enough buffer (50 mM Tris.HCl, 12.5 mM MgCl2, pH 8.0) to 
make a 500 µL reaction volume.  The reactions were incubated at 37oC and were 
analyzed by ESI-MS and MALDI/TOF-MS.  The mass data obtained showed 
optimal reaction times for all of the different phosphopantetheinylation reactions 
to occur (Table II-2).  The optimal reaction time found for acetoacetyl-CoA was 
used in the following PksG activity assays. 
 
Figure II-10  Mass spectrum showing mass of apo-AcpK+16 Daltons. 
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Table II- 2  Optimal incubation times for AcpK phosphopantetheinylation  
 reactions. 
II.D.4.b  Testing PksG Activity 
 Because the function of PksG was unknown, the correct combination of 
thioester pairs, CoA, AcpK, or PksL, which would yield the HMG product was 
unclear.  For this reason, the two simplest substrates were reacted first, 
acetoacetyl CoA and acetyl CoA.  According to results obtained we planned on 
progressively studying more difficult systems.  The products and substrates of 
acetoacetyl CoA and acetyl CoA PksG reactions were analyzed by High 
Pressure Liquid Chromatography (HPLC) analysis.  Results from these 
experiments showed PksG did not synthesize the expected HMG-CoA from 
these substrates.  It was then decided to check acetoacetyl-AcpK and acetyl CoA 
as substrates for PksG to determine if the enzyme could synthesize HMG-AcpK.  
These reactions were carried out by spectrophotometric analysis.   
For the spectrophotometric analysis the absorbance of the reaction was 
measured at 300 nm, because the acetoacetyl group on acetoacetyl-AcpK has a 
characteristic absorbance at that wavelength in the presence of Mg+2. A loss of 
absorbance was expected due to acetoacetyl-AcpK being depleted during a 
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synthesis of the HMG-AcpK product.  Reactions were carried out discontinuously 
every ten minutes for 1.5 hours.  The reaction showed no enzymatic activity by 
the spectrophotometric method when acetoacetyl-AcpK and acetyl-CoA were 
used as substrates.  In our next approach we were going to also monitor 
reactions using MADLI/TOF-MS; however, during these PksG studies another 
group determined the functionality of PksG.  Calderone, et al. found PksG 
synthesizes HMG-PksL from the substrates acetoacetyl-PksL and acetyl-AcpK 
(Calderone, et al., 2006).  PksL is a protein found in the genome of B. subtilis 
and contains two tandem ACPs.  Reactions involving variations of the published 
reaction were to be attempted; however, Calderone, et al. were able to determine 
PksG function before these reactions could be carried out.  A figure showing the 
reactions attempted and the one found to work by the other researchers can be 
seen in Figure II-11. 
 
Figure II- 11 Tested reactions involving PksG and published function of PksG  
 (Calderone, et al., 2006). 
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II.E Conclusions 
II.E.1  AcpK and Sfp Conclusions 
Purified His-Tagged AcpK from B. subtilis strain 168 was successfully 
produced with the use of pQE-60 overexpression vector and M15[pREP4] E. coli 
cells.  Purified His-Tagged Sfp, which was amplified from the pUC8/sfp 
overexpression vector, could also be produced using the pET-28a plasmid.  For 
both of these genes, ligation was efficient with T4 DNA ligase, and regulation of 
overexpression was performed using IPTG induction.  Ni-NTA chromatography 
was used to purify the AcpK and Sfp proteins due to the C-terminal His-Tag 
coded for by the pQE-60 plasmid for AcpK and the pET-28a plasmid for Sfp.  We 
were able to obtain large amounts of pure AcpK and Sfp from these systems. 
ESI-MS studies confirmed that Sfp has a wide range of ACP-substrate 
specificity, and conclusively determined the synthesis of apo-AcpK made by the 
overexpression strain pQE-60/acpK. We were able to use ESI-MS to determine 
the optimal reaction times for CoA and the various acyl CoAs. 
 
II.E.2  PksG Conclusions 
 Purified His-Tagged PksG from B. subtilis strain 168 can be produced with 
the use of pBAD overexpression vector.  Regulation of overexpression of 
pBAD/pksG was performed using arabinose.  Overexpressed PksG was purified 
using a Ni-NTA column since PksG was synthesized with a C-terminal His-Tag 
encoded by the pBAD plasmid.  To elute pure PksG from the column, 200 mM 
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imidazole was used.  Reactions performed that involved the PksG enzyme 
showed no activity.  The activity that was reported by Calderone, et al. showed 
PksG reacting with acetyl-AcpK with acetoacetyl-PksL to form HMG-PksL.  PksG 
apparently requires very specific protein-based substrates.  The work performed 
by Calderone, et al. proved the activity of PksG being that of a HMG-PKS 
synthase (Calderone, et al., 2006).  Though the chemical activity and protein 
scaffold specificity of PksG has been determined, the acyl substrate specificity 
has not yet been determined.  While chemical activity has already been shown, 
there is still question about its timing in polyketide synthesis, so we still require 
PksG for experiments that explore our hypotheses. 
 
II.F Experimental 
II.F.1.a Cloning and Overexpression of AcpK 
 The PCR to amplify AcpK used B. subtilis strain 168 genomic DNA as the 
template and 5’ TAT CCA TGG ATA AAC AGA GAA TCT TTG 3’ (inserts a NcoI 
site at the start) and 5’ TAT AGA TCT GGC AGA TTG CAC TTT GTC 3’ (inserts 
a BglII site downstream) as the primer pair. (Mootz, et al., 2001)  Vent 
polymerase was used to conduct the PCR with the following conditions: 94 oC for 
2 minutes; 30 cycles of 94 oC for 30 seconds, 60 oC for 30 seconds, and 65 oC
for 1.5 minutes.  The resulting PCR product and pQE-60 plasmid were digested 
separately using the restriction enzymes NcoI and BglII for the PCR product, and 
Bam HI and NcoI for the pQE-60 plasmid.  The digestion was carried out for 3.5 
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hours after which a 1.0% low melting agarose gel electrophoresis was performed 
to separate the digest fragments by size and visualized with UV light.  Plasmid 
and PCR product fragments were removed from the gel and melted in a 75 oC.  
These gel/DNA melts were used directly in ligation reactions using T4 DNA 
ligase and T4 DNA ligase buffer.  Multiple ligation reactions were performed 
using different insert to plasmid ratios.  These reactions were then transformed 
into competent E. coli DH5α cells and plated on LB plates containing 25µg/mL of 
ampicillin.   
The following day 10 transformants were selected and were used to 
inoculate 10x5 mL cultures with ampicillin (25µg/mL) grown overnight in a 37oC
shaker.  Nine cultures were purified (one did not grow) by the Qiagen Miniprep 
kit.  Each plasmid was screened for insert acceptance by a second PCR reaction 
using the respective purified plasmids as the template, and Vent polymerase with 
the same program seen above.  A 1.0% agarose gel electrophoresis was used to 
screen for the inserts in the vector.  One successful clone was chosen to be 
transformed into competent E. coli M15(pREP4) cells.   
 One colony was then used to make a starter culture, 5 mL of LB 
containing 30µg/mL of kanamycin and 25µg/mL of ampicillin.  One liter of LB 
containing 30µg/mL of kanamycin and 25µg/mL of ampicillin was inoculated with 
this starter culture and grown in a 37 oC shaker.  Growth was continued until an 
OD595 of 0.600-0.700 was reached.  IPTG was added to a final concentration of 
0.25 mM to induce the culture and growth was continued for three hours.  After 
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the three hours the cells were harvested by centrifugation (7500g for 30 minutes) 
and the resulting pellet was stored at -80oC.   
 
II.F.1.b Purification of AcpK 
 Cells from 1 L of LB culture were resuspended in 20 mL of binding buffer 
(5 mM imidazole, 500 mM NaCl, 20 mM Tris.HCl, pH 7.9) and were lysed by 
sonication on ice for three minutes.  The lysate was cleared by centrifugation 
(11000g for 30 minutes) and then applied to a Ni-NTA column containing 2mL of 
column bed, and the chromatography was conducted at 4oC.  After the loading of 
the crude extract the column was washed with 20mL of binding buffer.  Wash 
buffer (12mL) (60 mM imidazole, 500 mM NaCl, 20 mM Tris.HCl, pH 7.9) was 
used to remove nonHis-tagged proteins from the column.  The eluent buffer 
(12mL) which contained 200 mM imidazole, 500 mM NaCl, and 20 mM Tris.HCl, 
pH 7.9, was used to elute AcpK from the column.  Snakeskin® pleated dialysis 
tubing, having a 7000 Molecular Weight Cut Off (MWCO), was used for overnight 
dialysis of the eluted protein in 4L of buffer (50 mM Tris.HCl, pH 7.5) kept at 4oC.   
The dialyzed protein was concentrated by centrifuging using a Vivaspin 
5000 MWCO concentrator until the volume was between 500µL-750µL.  The 
concentration of AcpK was measured spectrophotometrically using the Bradford 
method.  Samples of Bovine Serum Albumin (BSA) were used for a standard 
curve having a range of concentrations between 0mg/mL to 1mg/mL and the 
OD595 was recorded at the different concentrations.  Concentrated AcpK was 
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then added to the Bradford reagent and the absorbance was measured to 
determine the protein concentration. 
 
II.F.2.a  Overexpression, and Purification of Wild-Type Sfp 
 Sfp had previously been cloned into the pUC8 plasmid by Nakano, et al. 
(Nakano, et al., 1992).  This plasmid was donated by Prof. Zuber (Oregon Health 
and Science University) and the overexpression and purification techniques 
outlined by his group were used.  First pUC8/sfp was transformed into competent 
E. coli MV1190 cells and plated on LB plates that contained 25µg/mL of 
ampicillin.  The next day a colony was used to inoculate a starter culture (5mL LB 
with 25µg/mL of ampicillin).  The following day, 1 L of 2xYT media was inoculated 
with the starter culture and the culture was shaken overnight at 37oC.  The cells 
were then harvested by centrifugation (7500g for 30 minutes).  The pellet was 
then resuspended in buffer (20 mM HEPES, 100 mM KCl, 1 mM EDTA, and 10% 
glycerol, pH 8.0) and sonicated on ice for three minutes.  To clear the lysate a 
second centrifuge step was used (11000g for 30 minutes).   
The supernatant was then fractioned by successive ammonium sulfate 
precipitations.  The first three ammonium sulfate concentrations, 35%, 50%, and 
65%, were used to precipitate nonspecific proteins from the crude extract.  For 
each step, the appropriate amount of ammonium sulfate was added to raise the 
percent concentration to the desired concentration all while incubation on ice for 
two hours.  After each precipitation the solution was then centrifuged for 10 
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minutes at 10000g. In the first three steps the supernatant was retained, while 
the pellet formed after centrifugation was discarded.  After addition of ammonium 
sulfate to 80% and incubation for two hours as before and being centrifuged, the 
pellet was retained and resuspended in buffer (20 mM Tris.HCl, pH 8.0).  Once 
the pellet was resuspended, it was dialyzed and concentrated by the same 
method used in the AcpK procedure seen previously, with the exception of the 
dialysis buffer being 20 mM Tris.HCl, pH 8.0. 
 
II.F.2.b  Cloning, Overexpression, and Purification of Sfp 
 The PCR to amplify Sfp from the pUC8/sfp plasmid as the template DNA 
was carried out using 5’ TCT ACC ATG GAG ATT TAC GCA ATT TAT ATG GAC 
CG 3’ (inserts a NcoI restriction site at the start) and 5’ GAG CCT CGA GTA AAA 
GCT CTT CGT ACG AGA CC 3’ (inserts a XhoI restriction site down stream) as 
the primer pair.  Phusion polymerase was used along with the following 
conditions: 30 seconds at 98oC; 30 cycles of 10 seconds at 98oC, 30 seconds at 
63oC, and 15 seconds at 72oC; and finally a hold of 5 minutes at 72oC.  The 
product from this PCR reaction, and the pET-28a plasmid were digested with 
NcoI and XhoI for 3.5 hours in separate reactions.  A 0.7% low melting agarose 
gel was used to separate the digested fragments and to visualize with UV light.  
The desired fragments were excised and placed in a hot water bath to melt the 
gel.  The solution containing the digested PCR fragment and digested plasmid 
52
were used in ligation reactions with T4 DNA ligase and T4 DNA ligase buffer.  
The ligation reactions were performed using varied insert:plasmid ratios. 
 The ligation reactions were transformed into competent E. coli DH5α cells 
and plated on LB-agar plates containing 30µg/mL kanamycin.  Two cultures were 
made from the two colonies that grew on one plate, 5mL LB containing 30µg/mL 
of kanamycin and shaken at 37oC.  Once the starter cultures had grown 
overnight, the plasmids were purified from the cultures using the Qiagen Miniprep 
Kit following the procedure outlined in the manufacturer’s instruction manual.  To 
screen for insert acceptance, a second PCR reaction was performed.  The 
parameters for the reaction were the same used in the first PCR reaction, with 
the only exception being the template DNA used was the purified plasmids.  A 
1.0% agarose gel electrophoresis was performed to visualize the PCR reaction 
mixtures.  A successful clone was transformed into competent E. coli BL21(DE3) 
cells.   
 One colony from this retransformation was grown overnight in a starter 
culture of LB and a concentration of 30µg/mL of kanamycin, and the following 
day 2 mL was added to 1L of LB containing 30µg/mL of kanamycin.  This was 
shaken at 37oC until the OD595 reached 0.500-0.600.  Once this absorbance was 
reached 1.0 mM of IPTG was added to the culture and was shaken overnight.  
The following morning the cells were harvested by centrifugation (7500g for 30 
minutes).  The pellet was then stored at -80oC until it was used for purification.  
To purify Sfp the same procedure outlined in II.F.1.b for the purification of AcpK 
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was used, with the only exception being the dialysis buffer was 50mM Tris.HCl, 
pH 7.5. 
 
II.F.2.c  Assays involving AcpK and Sfp 
 Reactions involving AcpK, Sfp, and acyl CoAs were conducted and the 
determination of phosphopantetheinyl reaction products was characterized by 
ESI-MS and MALDI/TOF-MS.  The reactions were conducted using various 
amounts of AcpK, Sfp, and acyl CoAs in buffer (50 mM Tris.HCl, 12.5 mM MgCl2,
pH 8.0) in a total reaction volume of 500µL.  After different incubation times, see 
Table II-2, the samples were prepared for analysis by ESI-MS.  First the reaction 
was filtered through a Fisherbrand nylon 0.45 µm syringe filter to remove any 
particulates from the reaction solution.  The filtered reaction was then mixed with 
methanol to a 1:1 ratio of methanol:reaction.  Finally, enough glacial acetic acid 
was added to give a 0.1% solution.  ESI-MS was carried out by a direct infusion 
method and analyzed in positive ion mode.  The peaks obtained were then 
deconvoluted to determine the molecular weight of the proteins in the different 
reactions. 
 For analysis by MALDI/TOF-MS, the reactions were prepared in the same 
manner as in the ESI-MS experiments.  To prepare the reactions for analysis, 
1µL of each reaction was added to 24µL of Matrix A (8mg of α-cyano-4-
hydroxycinnamic acid 99% dissolved in 1 mL of 0.3% aq. trifluoroacetic acid in 
50% acetonitrile).  Matrix A was prepared by vortexing for 20 seconds, followed 
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by centrifuging, and using the supernatant.  Each sample was spotted (0.5µL) on 
a MALDI sample loading plate and analyzed on an Applied Biosystem 4700 
Proteomics Analyzer.  Positive-ion mass spectra were recorded in the linear 
mode. 
 
II.F.3.a Overexpression and Purification of PksG 
 PksG had been previously cloned into the pBAD vector by Kevin Williams.  
The pBAD/pksG plasmid was transformed into competent E. coli TOP10 cells by 
the method outlined in the manufacturer’s manual and plated on LB-agar plates 
(25µg/mL ampicillin).  One colony from this plate was chosen and grown 
overnight in a starter culture, 5mL LB containing 25µg/mL ampicillin.  All 5mL of 
the starter culture was added to 1L of LB containing 25µg/mL ampicillin, and was 
shaken at 37oC until the OD595 reached 0.500-0.600 (mid-log phase).  At this 
point arabinose (0.01 M final concentration) was added to the culture and shaken 
for three hours at 37oC. The culture was harvested by centrifugation (7500g for 
30 minutes), and was stored at -80oC until purification was performed.  To 
perform the purification, the same method outlined in II.F.1.b for the purification 
of AcpK was used, with the only exceptions being the addition of 200µL of 
protease inhibitor (HALT™ Protease Inhibitor Cocktail) added prior to sonication 
and the dialysis buffer was 25mM Tris.HCl, pH 7.5. 
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II.F.3.b  Activity Assays with PksG 
 HPLC analysis was performed on a Varian Prostar HPLC and a Varian 
Microsorb C8 column (250mm in length and a 4.6mm inner diameter).  The two 
different solvents used were methanol and 100mM potassium phosphate, pH 7.0, 
containing 2 mM tetrabutylammonium phosphate (TBAP).  The gradient used for 
the HPLC analysis was 0% methanol increasing to 90% methanol over 20 
minutes.  This was held at 90% methanol 10 minutes and the methanol was 
decreased to 0% over 5 minutes.  The column was equilibrated in the phosphate 
buffer for 5 minutes.  A flow rate of 1 mL/minute was used, and the wavelength 
monitored was 219nm.  Acetoacetyl CoA, acetyl CoA, and HMG CoA were 
analyzed by this method to determine a standard elution time for each molecule.  
To test for PksG activity using the HPLC, one reaction containing all reactants 
and enzyme was prepared, and four control reactions were also mixed.  The full 
reaction contained 4mM acetoacetyl CoA, 4mM acetyl CoA, 16.5µg of PksG, and 
enough buffer (50mM Tris.HCl, 12.5mM MgCl2, pH 8.0) to yeild a 50µL reaction 
volume.  The controls were prepared the same way, but different components 
were omitted. 
 To spectrophotometrically monitor the PksG reactions using 
acetoacetyl-AcpK or acetoacetyl CoA and acetyl CoA, a Genesys10 
spectrophotometer was used.  To synthesize acetoacetyl-AcpK, apo-AcpK was 
mixed with acetoacetyl CoA and Sfp in reaction buffer, and was incubated for 30 
minutes at 37oC, according to the reaction protocol determined in section 
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II.D.4.a.  Three reactions were then prepared.  The first reaction contained 1mM 
acetoacetyl-AcpK, 1mM acetyl-CoA, and 3.3µg of PksG.  As a control for the first 
reaction 1mM acetoacetyl-AcpK was mixed with 1mM acetyl CoA, but no PksG 
was added.  The last reaction involved mixing 1mM acetoacetyl CoA, 1mM acetyl 
CoA, 3.3µg PksG in buffer (100mM HEPES, 0.1mM EDTA, 20mM MgCl2, pH 
8.0).  These reactions were incubated at 37oC and every ten minutes 25µL of the 
reaction was removed and dissolved in 475µL of buffer (100mM HEPES, 0.1mM 
EDTA, 20mM MgCl2, pH 8.0) to make the final acetoacetyl CoA and acetyl CoA 
concentration equal to 0.05mM.  Each of these samples was placed in a quartz 
cuvette with a 10.00mm pathlength, and the absorbance was recorded at 300nm. 
57
CHAPTER III 
 
OVEREXPRESSION, PURIFICATION, AND CHARACTERIZATION OF MMGA 
FROM BACILLUS SUBTILIS STRAIN 168 
 
III. A Introduction to MmgA 
III. A.1  MmgA and Proposed Activity 
 Certain bacteria, including Bacillus subtilis, when experiencing nutrient 
starvation, have the ability to sporulate.  Sporulation is considered a “last ditch” 
response when other survival strategies are not effective.  Such strategies can 
include activating flagellar motility to seek out nutrient sources, secretion of 
antibiotics to decrease competition by other organisms, and the secretion of 
hydrolytic enzymes to seek extracellular proteins and polysaccharides, among 
others.  The signal to begin sporulation is the phosphorylation of a protein called 
Spo0A.  Once Spo0A is phosphorylated, the expression of genes used in the 
sporulation process is initiated (Stephens, et al., 1988). 
An operon used in sporulation from Bacillus subtilis strain 168 was 
discovered in 1996.  This operon was called the mother cell metabolic genes 
(mmg) and is under the control of the σE factor, which is used to express genes 
at the intermediate stages of sporulation.  The operon includes mmgA-E and the 
gene yqiQ, with mmgA-C having sequence homology to genes used in fatty acid 
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metabolism (Bryan, et al., 1996; Subtilist Web Server, accessed March 12, 
2007).  The genes mmgDE and yqiQ show homology the genes used in 
propionate metabolism in E. coli with the products of these reactions yielding 
citric acid cycle substrates.  The gene mmgA, specifically, is an acetyl coenzyme 
A (CoA) acetyltranferase homolog (Bryan, et al., 1996).  Acetyl-CoA 
acetyltransferases catalyze the synthesis of acetoacetyl CoA by the 
condensation of two molecules of acetyl CoA.  These types of enzymes have 
also been shown to catalyze the reverse reaction, called a thiolysis reaction, 
which uses one CoA to cleave an acetoacetyl CoA unit into two acetyl CoA 
molecules.  These reactions are shown in Figure III-1.   
 
Figure III- 1 Reaction of acetyl coenzyme A acetyltransferases. 
 
Because MmgA has not been biochemically proven to be an acetyl-CoA 
acetyltransferase, it is an interesting enzyme to study.  Along with the 
determination of the proposed functionality of the enzyme an investigation of its 
substrate specificity will also be investigated.  Other enzymes of the same class 
as MmgA have been able to synthesize β-keto acyl CoAs longer then acetoacetyl 
CoA (Antonenkov, et al., 1997).  Also, we intend to investigate whether MmgA 
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can thiolyze long chain β-keto bonds. (see Figure III-2).  MmgA may cleave 
longer β-keto acyl bonds due to the presence of branched or odd chain fatty acid 
bonds produced by the organism.  However, in order to study these reactions, 
the synthesis of long chain β-ketos will have to be performed, since these 
compounds are not available commercially. 
 
Figure III- 2 Thiolysis of different length β-keto acyl coenzyme A bonds using  
 MmgA. 
 
III.A.2  MmgA and the Synthesis of Difficidin 
Once the functionality of MmgA has been determined, the protein can be 
used as a synthetic tool to aid our investigation of the biosynthesis of difficidin.  
Two different hypothesis have been proposed for the synthesis of difficidin.  The 
first hypothesis involves PksG synthesizing an HMG precursor molecule that can 
then be reacted with other enzymes and finally added to the nascent difficidin 
chain by polyketide synthases (see Figure III-3).  The second hypothesis involves 
a full-length difficidin intermediate that is synthesized by standard polyketide 
60
chemistry.  This intermediate would contain a ketone at the C3 position which is 
modified by other enzymes (PksFGHI) and a unit of acetyl-AcpK to form difficidin.  
These two hypotheses can be seen in the following figures (Figure III-3, Figure 
III-4). 
 
Figure III- 3 First hypothesis for difficidin production. 
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Figure III- 4 Second hypothesis for difficidin production. 
 
Since PKSs have extremely large masses, from 100 to 10,000 kiloDaltons, 
it is very difficult to determine which hypothesis is valid (Khosla, et al., 1999).  
One approach can utilize a PksG- mutant of B. subtilis strain 39374, the producer 
of difficidin (Zweerink, et al., 1987).  PksG, a 3-hydroxy-3-methylglutaryl (HMG) 
synthase, acts on either the acetoacetyl group attached to one thiolation domain 
on PksL, or on a long-chain difficidin precursor molecule.  PksG is an important 
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step in the synthesis of difficidin and by removing this enzyme from the difficidin 
synthesis process it is possible to reveal the biochemical role of this enzyme.  A 
PksG- mutant would not be able to synthesize the HMG intermediate, so a 
labeled replacement substrate, 13C labeled 3-hydroxy-3-methylglutaryl- N-
acetylcysteamine (HMG-SNAC), will be introduced to a culture of the PksG- B. 
subtilis 39374 mutant.  If the first hypothesis is correct, the culture will then 
directly use the labeled HMG-SNAC, and produce a labeled 3-keto difficidin 
precursor product, which can be detected using mass spectral analysis.  If the 
second hypothesis is correct, the culture will not be able to use this labeled 
substrate and we can instead expect a new difficidin derivative having a ketone 
group at the C3 position. 
Labeled HMG-SNAC is not commercially available, so a synthesis in our 
lab is necessary.  The synthesis of HMG-SNAC would occur in the following 
steps (Figure III-5).  First, labeled pyruvate will be reacted with CoA and NAD+ to 
produce labeled acetyl CoA, in a reaction catalyzed by a commercially available 
pyruvate dehydrogenase.  MmgA would then be used with two labeled acetyl 
CoA units to produce labeled acetoacetyl CoA.  Labeled HMG-CoA will be 
produced by a HMG-CoA synthase from Staphylococcus aureus using labeled 
acetoacetyl CoA and labeled acetyl CoA (Campobasso, et al., 2004).  Finally, 
HMG-CoA will be reacted with SNAC to make labeled HMG-SNAC. 
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Figure III- 5 Synthesis of labeled 3-hydroxy-3-methylglutaryl-N-acetylcysteamine. 
 
III.B Production and Characterization of pET-28a/mmgA 
III.B.1 Goals 
 In order to test our hypothesis for the activity of MmgA, pure MmgA would 
be needed from B. subtilis strain 168.  The first step was to clone and 
overexpress mmgA using the pET-28a plasmid.  Overexpressions with pET 
plasmids involve the bacteriophage T7 promoter and T7 RNA polymerase.  For 
pET-28a the LacI repressor protein controls the T7 promoter, making the pET 
system able to be externally controlled (pET System Manual, 5th ed.).  Once 
induction occurs, the cell begins to use most of its resources to transcribe the 
gene under control of the T7 promoter, known as “overexpressing” the gene.  
The amount of production can in principle be controlled by changing the amount 
of inducer added.  MmgA in this case would be the gene of interest, and would 
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be cloned into the pET-28a plasmid by restriction digesting the pET-28a vector 
and PCR-amplified mmgA. This will be followed by performing a subsequent 
ligation using T4 DNA ligase.  Overexpression of the protein involves growing a 
culture of cells to mid-log phase and then inducing the growth by adding an 
inducer.  A LacI repression system, like the pET vector, can use isopropyl-beta-
D-thiogalactopyranoside (IPTG) as an inducer.  IPTG is an artificial inducer of the 
lac operon and addition of this inducer leads to the production of large amounts 
of the protein of interest.  Once mmgA is successfully cloned into pET-28a, the 
next goal would be to purify the overexpressed MmgA.   
Nickel-affinity purification would be used because the protein would be 
cloned with a C-terminal histidine-tag encoded by the plasmid.  His6-tagged 
proteins can be purified by affinity chromatography using a nickel-nitrilotriacetic 
acid (Ni-NTA) column.  NTA is a Ni+2-chelating adsorbant which leaves two 
empty sites on the nickel for binding nitrogens of the His6-tag.  Washes with low 
imidazole concentrations remove nonHis-tagged proteins from the column, while 
the His6-tag of the protein associates strongly with the Ni2+ on the column.  A 
buffer with high imidazole concentration is used to elute the purified protein from 
the column. 
 The last goal would be to characterize the enzymatic activity of MmgA in 
both the condensation and thiolysis directions.  We expect that MmgA can 
catalyze the condensation of two acetyl-CoA molecules to form acetoacetyl-CoA, 
or thiolyze the β-keto bond of acetoacetyl-CoA in the presence of CoA to form 
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acetyl-CoA.  UV-Vis spectrophotometric analysis will be used to test the kinetics 
of the reactions, and High Performance Liquid Chromatography (HPLC) analysis 
will be used to conclusively identify the substrates and products.  UV-Vis 
spectrophotmetric analysis has been used to test for acetyl-CoA acetyltranferase 
activity in the past.  The β-keto group of acetoacetyl coenzyme A, in the 
presence of Mg2+, absorbs around 300 nm.   
 
III.C Results 
III. C.1 Cloning of mmgA 
 Primers for the polymerase chain reaction (PCR) were designed and used 
to amplify mmgA from the B. subtilis 168 genome.  The gene fragment produced 
had sequence coding on each end that inserts an NcoI site at one end and an 
XhoI site on the opposite end.  MmgA has a gene length of 1179 base pairs (bp).  
A band at ~1200 bp appeared on an agarose gel, indicating the PCR was 
successful.   
 Insertion into the pET-28a vector was attempted using NcoI and XhoI on 
both the plasmid and mmgA PCR product.  T4 DNA ligase was used to ligate the 
restriction digested products together.  Different ratios of insert:plasmid were 
used in six separate reactions.  Once the ligation/cloning step was complete the 
ligation mixture was transformed into competent E. coli DH5α cells.  The 
transformed cells were then plated on six agar plates containing kanamycin 
(30µg/mL) and were incubated overnight at 37oC.  The following morning each 
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plate had several transformants.  Colonies from one plate were selected and six 
starter cultures were grown overnight.  The plasmids were then purified from the 
cultures the next day and another restriction digest was performed to test for 
insert acceptance into the plasmid.  An agarose gel showed that all of the 
plasmids contained an insert and the first plasmid was chosen to be transformed 
into competent E. coli BL21(DE3) cells. 
 
III.C.2  Overexpression and Purification of pET-28a/mmgA 
 The gene of interest, mmgA, had been successfully cloned into pET-28a 
which codes for a C-terminal His-tag.  Our next step was to overexpress the 
protein from the clone.  The overexpression strain pET-28a/mmgA was grown in 
Luria Bertani (LB) medium containing 30µg of kanamycin per mL at 37 oC in a 
shaker until the optical density reached between 0.400 and 0.450 at 595nm.  The 
culture was then moved to an 18oC shaker until it reached an absorbance 
between 0.500 and 0.600 at 595nm.  Once this absorbance was reached the 
culture was induced with 1.0mM IPTG.  The culture was then shaken overnight, 
and the cells were harvested the next day by centrifugation (9950g for 30 
minutes).  The cells were then resuspended in 20mL of Binding buffer (5mM 
imidazole, 500mM NaCl, 20mM Tris, pH 7.9) and lysed by sonication.  The lysate 
was cleared by centrifugation (11000g for 30 minutes). 
 Because inclusion bodies were found to be a problem, a low incubation 
temperature was determined to be necessary since whole cell SDS-PAGE 
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(Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophorisis) samples of 
cultures grown at 37oC showed a band with high expression with a molecular 
weight consistent with MmgA, but none of this material was found in the postlysis 
supernatant.   
 The centrifuged lysate was then applied to a Ni-NTA (Nickel- nitrilotriacetic 
acid) column and was kept at 4oC.  Different concentrations of imidazole, 5mM 
and 60mM was used to wash nonHis-tagged proteins from the column.  A final 
buffer containing 200mM imidazole was used to elute the protein.  An SDS-
PAGE was taken of samples taken from various stages of the chromatography.  
The expected mass of MmgA is 42.1 kDa.  The SDS-PAGE gel shown in Lane 6 
of Figure III-6 shows a large band below the 45.0 kDa molecular weight marker.  
The eluted protein from the column was dialyzed overnight in buffer containing 
25 mM Tris HCl, pH 7.5.  The protein was then concentrated the next morning by 
centrifugation using a Vivaspin 5000 Molecular Weight Cut Off (MWCO) 
concentrator.  Sterile glycerol was then added to the protein to a final 
concentration of 10% for -80oC storage.  The concentration of the protein was 
then determined spectrophotomectrically using the Bradford method.  The 
average concentration of MmgA was ~ 675µg per 1L of culture. 
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Figure III-6 Sodium dodecyl sulfate polyacrylamide gel electrophorisis of  
column chromatography of MmgA purification. 
 
III.C.3 Testing MmgA Activity 
III.C.3.a Spectrophotometric Analysis of MmgA Reaction Kinetics 
 Our hypothesis is that MmgA catalyzes the synthesis of an acetoacetyl 
coenzyme A, or the CoA-dependant thiolysis of acetoacetyl CoA with the 
production of two acetyl CoAs.  To test for this activity, and to also measure the 
kinetics, a spectrophotometric method was used.  The reaction is able to be 
monitored spectrophotometrically due to Mg+2 being present in the buffer used for 
the reactions.  The enolate form of the β-keto group on acetoacetyl CoA absorbs 
at 300 nm, and this form is stabilized by Mg+2 (Pantazaki, et al., 2005). 
The simplest case of rate kinetics for enzymes is single substrate rate 
kinetics where the substrate in the presence of the enzyme is converted to 
product, PESESE +↔•↔+ . The Michaelis-Menten equation for a single 
substrate reaction is 
][
][max
SK
SVv
M +
= where Vmax is the maximum rate an enzyme 
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can catalyze a reaction at a specific enzyme concentration, and KM is the 
substrate concentration the results in a reaction rate at 1/2Vmax. Acetyl CoA 
acetyltranferases catalyze a multi-substrate reaction, and are known for having a 
“ping-pong” mechanism, which leads to a more complicated rate equation, 
]][[][][
]][[max
BAAKBK
BAVv B
M
A
M ++
= , where A is substrate1 and B is substrate2.  Rate data 
from this type of reaction would be laborious to obtain; however, it is possible to 
create a pseudo-single substrate reaction if one substrate is held at a high, 
saturating concentration such as if acetoacetyl CoA were held at saturating 
conditions then the rate of the reaction would depend on the concentration of 
CoA.  The rate equation in this case would simplify to, 
][
][max,
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single substrate kinetics can be used to determine an apparent Vmax for the 
reaction and an apparent KM for both substrates, acetoacetyl CoA and CoA. 
To accomplish this, the concentration of acetoacetyl CoA was held 
constant at 60µM, while the concentration of CoA was varied, and the rate of 
reaction was recorded for each varied concentration.  The reactions were carried 
out for 0.3 minutes at a constant temperature of 30oC.  The KM,app for CoA was 
52µM, and the Vmax,app was found to be 2.2µM/sec from a double reciprocal plot 
of 1/substrate concentration versus 1/ average rate of reaction (see Figure III-7). 
The kinetic parameters for acetoacetyl CoA were obtained in a similar 
manner. The concentration of CoA was held constant at 70µM, and the 
concentration of acetoacetyl CoA was varied.  The amount of enzyme used in 
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each 1mL total reaction volume was 1.0µg of MmgA.  Concentrations above 
70µM CoA showed substrate inhibition since the rate of the reaction decreased 
with concentrations of CoA above 70µM. 
 Figure III-7 shows the graph of the acetoacetyl CoA rate data obtained.  
Though there are six points on the graph, only four were used because they are 
in the linear range of the graph.  The kinetic parameters found for acetoacetyl 
CoA were a KM,app of 770µM and a Vmax,app of 10µM/sec.  The trend that is seen in 
Figure III-7 shows that as the points approach the reciprocal velocity axis the line 
began to level out.  This shape shows a classic plot shape for substrate 
inhibition.  In another study, done by Middleton, an acetoacetyl CoA thiolase from 
rat liver showed substrate inhibition by CoA (Middleton, 1974).  In this report a 
double reciprocal plot of 1/velocity versus 1/concentration of CoA was given.  
The plot obtained started to curve up as the line approached the 1/velocity axis 
(see Figure III-8).  This led Middleton to conclude that CoA does inhibit the 
thiolase enzyme (Middleton, 1974).  A similar shape can be seen in the graph in 
the acetoacetyl CoA plot in Figure III-7, which suggests acetoacetyl CoA is 
inhibiting the reaction as well as CoA for the protein MmgA.  Once the kinetic 
constants had been estimated for the reaction the identification of the products of 
the thiolysis reaction would be carried out using High Performance Liquid 
Chromatography (HPLC) analysis.   
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Figure III- 7 Double reciprocal plot of coenzyme A and acetoacetyl coenzyme  
A thiolysis rate data. 
 
Figure III-8 Inhibition of rat liver acetoacetyl coenzyme A thiolase by   
coenzyme A (Middleton, 1974). 
 
The condensation reaction was carried out in the spectrophotometer using 
the same buffer and temperature as the thiolysis reaction.  The condensation 
reaction uses acetyl CoA as the substrate.  Reactions containing 60 µM acetyl 
CoA were carried out over a 30 minute time period, which showed no acetoacetyl 
CoA being formed.  To see if MmgA had a broader substrate specificity, 
reactions containing butyryl CoA and acetyl CoA were performed.  Varying 
concentrations of acetyl and butyryl CoA were used.  Enzyme (1.0µg.mL) was 
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added, and the reaction was monitored over 30 minutes to see if MmgA could 
synthesize a longer chain β-keto acyl CoA.  The spectrophotometric assays did 
not show any activity for this reaction, and it was decided HPLC analysis would 
be used to conclusively determine whether MmgA was able to successfully 
perform a condensation reaction. 
 
III.C.3.b High Performance Liquid Chromatography (HPLC) of MmgA Reaction  
 Products 
 Once the spectrophotometric measurements had been taken, the next 
step was to use HPLC to confirm the products of the MmgA reactions.  CoA, 
acetoacetyl CoA, acetyl CoA, and butyryl CoA were used to determine the elution 
times for each substrate.  Reactions in both the thiolysis direction and the 
condensation direction were conducted, with samples being run on the HPLC at 
different times during the reaction.  The standard elution times can be seen in 
Table III-1. 
 
Table III- 1 Standards of MmgA substrates and elution times. 
In the thiolysis reaction, the peak associated with acetoacetyl CoA, after 
three hours of reaction time, completely disappeared, and a peak with the same 
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retention time as acetyl CoA appeared gradually over the same three hour 
period.  This process can be seen in the following figure. 
 
Figure III- 9 Thiolysis reaction showing loss of acetoacetyl coenzyme A peak  
 and appearance of acetyl coenzyme A peak over three hours. 
 
For the condensation reaction, the acetyl CoA peak did not decrease; 
however, a peak associated with CoA did begin to appear after an hour of 
reaction time.  When left to react overnight the CoA peak increased and the 
acetyl CoA peak did decrease, but a peak associated with acetoacetyl CoA was 
never detected.  This would not be an unexpected result with an enzyme that 
shows a ping-pong type mechanism, a mechanism other acetyl CoA 
acetyltransferases have been reported to undergo (Pantazaki et al., 2005).  
Acetyl CoA would enter the active site of the enzyme and an active site cysteine 
would then initiate a nucleophilic attack on the carbonyl carbon, releasing CoA.  
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This would also form an enzyme-acetyl intermediate.  If the enzyme was able to 
form acetoacetyl CoA then another unit of acetyl CoA would enter the active site 
and through a Claisen like condensation releasing acetoacetyl CoA.  Figure II-
10A shows acetyl-CoA in reaction buffer before addition of MmgA and Figure III-
10B shows the condensation reaction after being incubated at 37oC overnight.  
Reactions involving butyryl CoA also showed the development of a peak 
associated with CoA, but a condensation product was never detected. 
 
Figure III-10 Condensation reaction (A) before MmgA is added and (B)  
after MmgA is added and incubated overnight. 
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III.D Conclusion 
Purified His-Tagged MmgA from B. subtilis strain 168 was successfully 
produced with the use of pET-28a overexpression plasmid vector.  IPTG 
induction was used to regulate the overexpression of MmgA-pET-28a, and a 
lower incubation temperature was at least partially effective in reducing inclusion 
bodies.  A Ni-NTA column was used to purify MmgA since it was cloned with a C-
terminal His-Tag encoded by the pET-28a plasmid. 
 MmgA activity was studied in two ways; spectrophotometrically, and by 
HPLC.  The spectrophotometric measurements also gave the kinetic constants 
for the enzyme reactions.  The loss of absorbance at 300nm was proportional to 
the loss of acetoacetyl CoA.  This loss of substrate correlated with the proposed 
function of the enzyme.  These rate studies also showed that both acetoacetyl 
CoA and CoA exhibit substrate inhibition at high concentrations. 
For HPLC analysis, an isocratic method was used and standards of CoA, 
acetyl CoA, and acetoacetyl CoA were analyzed.  The retention times of these 
standards were used to compare to determine the identity of the components of 
MmgA reactions catalyzed.  The HPLC analysis showed a loss of acetoacetyl 
CoA, and the production of acetyl CoA, with the reaction going to completion 
after three hours.  Both the spectrophotometric analysis and HPLC confirmation 
demonstrated that MmgA is a thiolase.  MmgA was shown not to produce 
acetoacetyl CoA in the condensation reaction, or a longer chain β-keto from 
reactions with butyryl CoA, though the production of CoA was noted over time. 
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Though MmgA does not show condensation activity it does show activity 
in the thiolation direction.  This makes MmgA ineffective for the proposed 
synthesis of labeled HMG-SNAC (see Figure III-5).  Though MmgA will not be 
used for this synthesis, other enzymes that show this activity from other 
organisms can easily be obtained and utilized for the synthesis studies.  Because 
the activity of MmgA had not been determined, the results from this thesis are of 
scientific value. 
The researchers who discovered this operon proposed the physiological 
function of the mmg operon was to gain energy from fatty acid metabolism.  The 
importance of MmgA in this energy harvesting processes can be hypothesized 
from the results presented in this work.  The operon containing mmgA can be 
seen in Figure III-11.  One gene, yqiQ, has not been officially designated an mmg 
gene; however, the location of transcription termination sequence indicates that it 
is likely part of the mmg operon.  Based on this signal and the expected functions 
described below we suggest that yqiQ be renamed mmgF and yqiQ will be 
referred to as mmgF for all further discussions. 
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Figure III-11 Portion of Bacillus subtilis genome containing mmg operon 
(Subtilist Web Server, accessed March 12, 2007). 
 
The genes mmgB and mmgC are homologs of 3-hydroxybutyryl-CoA 
dehydrogenases and acyl-CoA dehydrogenases, respectively.  These enzymes 
are expected to oxidize a fatty acyl-CoA to a β-keto fatty acyl CoA.  MmgA can 
then cleave the β-keto bond yielding acetyl CoA.  MmgD shares homology with 
citrate synthase III which catalyzes the condensation of acetyl-CoA and 
oxaloacetate in the presence of water to yield citrate and CoA.  This citrate is a 
substrate for the citric acid cycle, therefore this is an apparent path fatty acids 
can be harvested for energy metabolism.  In the case of even chain fatty acids, 
this pathway may be used; however, B. subtilis is known to synthesize branched 
chain and odd chained fatty acids and would be available to the organism for 
energy (Oku, et al., 1988; Kaneda, et al., 1967).  In this case the first two steps 
involving MmgABC would remain the same with the exception being the product 
of the MmgA reaction would be a propionyl-CoA unit instead of acetyl-CoA (see 
Figure III-12).   
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The next enzyme, MmgD, would then synthesize a methylcitrate from 
propionyl-CoA and oxaloacetate.  MmgE shares strong sequence homology to 
prpD from E. coli as shown by a Basic Local Alignment Search Tool (BLAST) 
search of the protein sequence of mmgE on the Colibri web server (Colibri Web 
Server, accessed March 12, 2007).  The prpD gene is located in a propionate 
catabolism operon and catalyzes the reaction of methylcitrate to methylaconitate 
which in a subsequent step is rehydrated synthesizing methylisocitrate (Brock, et 
al., 2002).  Finally, mmgF shows strong homology to the gene prpB of E. coli also 
located in the propionate metabolism operon.  The enzyme PrpB is a 
methylisocitrate lyase which breaks methylisocitrate into pyruvate and succinate 
(Brock, et al., 2002).  Succinate is a well known citric acid cycle intermediate.  
Whether or not MmgA is able to cleave a longer chain β-keto acyl CoA is still to 
be determined.  The rest of the operon would also need to be characterized in 
order to determine how B. subtilis uses this operon in sporulation.  The 
hypothetical pathways that lead to the citric acid cycle from fatty acid metabolism 
using this operon can be seen in Figure III-12. 
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Figure III-12 Hypotheses for fatty acid catalysis pathway in the mmg operon. 
 
III.E Experimental 
III.E.1  Cloning and Overexpression of MmgA 
 MmgA was PCR amplified using the primers 5’ AAA CCA TGG GGA AAA 
CAG TCA TTG TAA GTG CTG 3’ (contains a NcoI restriction site) and 5’ CAT 
CTC GAG ATG AAC CTG CAC TAA GAC G 3’ (contains an XhoI restriction site).  
Phusion polymerase was used along with the following conditions: 30 seconds at 
98 oC; 30 cycles of 10 seconds at 98 oC, 30 seconds at 61 oC, and 30 seconds at 
72 oC; and finally a hold of 5 minutes at 72 oC.  The product from the PCR 
reaction and the pET-28a plasmid were digested with NcoI and XhoI for 3.5 
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hours in separate reactions.  A 0.7% low melting agarose gel was used to 
separate the digested fragments and to visualize with UV light.  The desired 
fragments were then removed from the gel and placed in a hot water bath to melt 
the gel.  This solution containing the digested PCR fragment and the digested 
plasmid were used in ligation reactions with T4 DNA ligase and T4 DNA ligase 
buffer. Six ligation reactions were performed, three with the insert plasmid ratio of 
5 µL:1µL, and the second three with the ratio of 5µL:2µL.   
 The ligation reactions were transformed into competent E. coli DH5α cells 
and plated on LB-agar plates containing 30µg/mL of kanamycin.  Six starter 
cultures, 5mL LB containing 30µg/mL of kanamycin shaken at 37oC, were made 
from colonies grown on various plates from the ligation.  After the starter culture 
had grown overnight, the plasmids were purified from the cultures using the 
Qiagen Miniprep kit following the procedure outlined in the manufacturer’s 
instruction manual.  To screen for insert acceptance, a second restriction digest 
was performed with the same restriction enzymes used in the first digest 
reaction.  After the plasmids had digested for 3.5 hours, 1.0% agarose gel 
electrophoresis was performed to visualize the plasmids with the accepted insert.  
A successful clone was transformed into competent E. coli BL21(DE3) cells.  
 One colony from this retransformation was grown overnight in a starter 
culture of LB and a concentration 30µg/mL of kanamycin.  Two mL of the starter 
culture was then added to 1 liter of LB containing 30µg/mL of kanamycin, and 
was shaken at 37oC until the OD595 reached 0.400-0.450.  Once this OD was 
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reached the culture was shaken at 18oC until an OD595 of 0.500-0.600 is 
observed.  1.0 mM of IPTG was then added and the culture was then allowed to 
grow overnight.  The following morning the cells were harvested by centrifugation 
(9950g for 30 minutes).  The pellet was then stored at _80oC until it was used for 
purification. 
 
III.E.2 Purification of MmgA 
 The pelleted cells obtained from the overexpression were resuspended in 
20 mL of binding buffer (5mM Imidazole, 500mM NaCl, 20mM Tris.HCl, pH 7.9) 
and lysed by sonication on ice for 3 minutes.  The lysate was then removed by 
centrifugation (11000g for 30 minutes) and applied to a Ni-NTA chromatography 
column containing 2mL of column bed.  The chromatography was conducted at 
4oC.  The crude extract was loaded first, followed by a wash of 20mL of binding 
buffer.  Wash buffer, 12mL, (60mM Imidazole, 500mM NaCl, 20mM Tris.HCl, pH 
7.9) was added to remove nonHis-tagged proteins from the column.  The Eluent 
buffer, 12mL, (200mM Imidazole, 500mM NaCl, 20mM Tris.HCl, pH 7.9) eluted 
MmgA from the column.  Snakeskin® pleated dialysis tubing with a 7000 MWCO 
was used to dialyze the eluent overnight in 4L of buffer containing 25mM 
Tris.HCl, pH 7.5.  The dialyzed protein was then concentrated by using a 
Vivaspin 5000 MWCO concentrator until the volume read 500µL to 750µL.  An 
SDS-PAGE was used to determine the purity of MmgA.  The concentration of the 
protein was then measured spectrophotometrically using the Bradford method.  
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The absorbance of the reagent plus the enzyme at 595nm was recorded.  Using 
a standard curve of absorbance versus protein concentration, the concentration 
of MmgA obtained from the overexpression/purification was determined.   
 
III.E.3  Spectrophotometric Analysis of MmgA Activity 
 Using the Cary BIO 100 UV.Vis spectrophotometer reaction mixtures 
containing CoA, acetoacetyl CoA, and MmgA were analyzed.  To determine the 
reaction constants for coenzyme A a constant concentration of acetoacetyl CoA 
was used in each reaction(60µM), and varying concentrations of CoA (5µM, 
10µM, 15µM and 20µM), MmgA was added to give a final concentration of 
1.0µg/mL.  In a quartz cuvette with a 10.00mm pathlength the acetoacetyl CoA 
and MmgA were added into enough buffer (100mM Tris, 25mM MgCl2, pH 8.1) 
so that the total reaction volume equaled 1.0mL.  The cuvette was then placed in 
the spectrophotometer with a constant temperature of 30 oC.  To begin the 
reaction the appropriate amount of CoA was added to the reaction.  The reaction 
was then monitored at 300 nm for 0.3 minutes using the program Win UV 
Kinetics Application.   
Once the program had finished recording the absorbance versus time, the 
data was then exported into a Microsoft Excel spread sheet.  A linear curve fit 
was used to obtain an equation from each reaction.  All reactions were done in 
triplicate to obtain an average rate.  The absorbance of acetoacetyl CoA, when 
placed in the spectrophotometer in buffer without CoA of MmgA, decreased over 
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time.  To account for this in the rates of each reaction, acetoacetyl CoA in buffer 
was placed in the spectrophotometer, at the same reaction concentration, and 
the rate of decay obtained from an average of three readings was subtracted 
from each rate obtained for all the reactions before the reaction rates were 
averaged.  A reported ε300 of 3600 M-1cm-1 for acetoacetyl CoA was used to 
calibrate the absorbance data. (Kornblatt, et al., 1971)  A double reciprocal plot 
of the rate of reaction versus the concentration of CoA was used to determine the 
kinetic constants KM and Vmax.
Once the constants for CoA had been determined, the kinetic parameters 
for acetoacetyl CoA were measured.  For these reactions, the concentration of 
CoA was held constant (70µM) and the acetoacetyl CoA concentration was 
varied (5µM, 10µM, 20µM, 30µM, 40µM, and 50µM).  The same 
spectrophotometric parameters were used as in the previous reactions: 10.00mm 
quartz cuvette, 30oC, absorbance monitored at 300nm.  Acetoacetyl CoA was 
added to buffer (100mM Tris, 25mM MgCl2, pH 8.1) and 1.0µg of MmgA.  The 
reaction was started with the addition of CoA and the reaction was monitored for 
0.3 minutes.  After the data was imported into a Microsoft Excel spread sheet 
and a linear curve fit was applied, the rate was recorded.  All concentrations were 
repeated at least three times, and the rate obtained for the specific 
concentrations was an average of the values.  To account for any decay in 
absorbance signal, acetoacetyl CoA was added to the cuvette at the different 
concentrations in the reactions without CoA or MmgA and the change in 
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absorbance was recorded a minimum of three times.  These values were then 
averaged.  The rate of decay associated with the different concentrations of 
acetoacetyl CoA was subtracted from the reaction rates before the individual 
reaction rates were averaged.  After averaging, a reported ε300 of 3600M-1cm-1 for 
acetoacetyl CoA was used to obtain concentration versus time for the reaction 
(Kornblatt, et al., 1971). 
The condensation reaction using acetyl CoA (60µM) and MmgA (1.0µg) in 
enough buffer (100mM Tris, 25mM MgCl2, pH 8.1) to make 1mL total reaction 
volume was measured.  A 10.00mm quartz cuvette was used in the reactions 
and each reaction was held at 30oC.  The reaction was started with the addition 
of MmgA, and the absorbance was monitored at 300nm for 30 minutes.  After 30 
minutes there was no increase in absorbance.  We therefore analyzed the same 
reaction by HPLC as described below. 
The synthesis of a long chain β-keto acyl CoA was carried out by reacting 
acetyl CoA with butyryl CoA in the presence of MmgA.  The reaction was started 
with the addition of MmgA, and the absorbance was monitored at 300nm for 30 
minutes.  After 30 minutes there was no increase in absorbance.  We therefore 
analyzed the same reaction by HPLC as described below 
 
III.E.4  HPLC Analysis of MmgA Reaction Products 
 MmgA reaction products and standards were analyzed using a 
Varian Prostar HPLC.  For all reactions and standards a buffer (95% 200mM 
85
Ammonium acetate, pH 6.0; %5 acetonitrile) was conducted at 1mL/min for 15 
minutes with absorbance being monitored at 261nm.  The column used was a 
Waters NovaPak C18 reverse phase column of 4µm particle size, 150mm in 
length, and a 3.9 mm inner diameter (Burns, et al.).  Standards of CoA, acetyl 
CoA, acetoacetyl CoA, and butyryl CoA were used to determine the elution time 
of the compounds.  The thiolysis reaction was conducted in an HPLC sample vial 
and contained 70µM CoA, 50µM acetoacetyl CoA, and 0.25 µg of MmgA in 
enough buffer (100mM Tris, 25mM MgCl2, pH 8.1) to make 1 mL total reaction 
volume.  Samples were run through the HPLC were before addition of MmgA, 30 
minutes after addition of MmgA, 2 hours, 3 hours, and 4 hours after addition of 
MmgA.  The reaction was incubated at 37oC between HPLC runs.  Formation of 
reaction products was determined by comparison of chromatographic peaks from 
the reaction and the standards. 
The condensation reaction was carried out in an HPLC sample vial 
containing 60µM acetyl CoA, 1.0µg of MmgA, and enough buffer (100mM Tris, 
25mM MgCl2, pH 8.1) to give a total of 1mL reaction volume.  Before MmgA was 
added to the reaction, acetyl CoA in buffer was applied to the column.  Once the 
reaction had been started with the addition of the enzyme, a sample was 
analyzed every hour for 2 hours, and an overnight sample was analyzed the next 
day.  The reaction was incubated at 37oC between all timed runs on the HPLC.  
Reaction products were determined by comparing the obtained chromatographic 
peaks to those of the standard peaks. 
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For HPLC analysis of the condensation reaction involving butyryl CoA, 
60µM acetyl CoA, and 50µM butyryl CoA were used.  MmgA (1.0µg) was used in 
the reaction with enough buffer (100mM Tris, 25mM MgCl2, pH 8.1) to make 1 
mL total reaction volume.  The mixture of butyryl CoA and acetyl CoA was added 
to the column before addition of MmgA using the program of 15 minutes at 95% 
200mM ammonium acetate, 5% acetonitrile followed by an increase of 
acetonitrile to 60% over five minutes and was held constant at this percentage for 
another five minutes.  The acetonitrile was then increased to 80% over five 
minutes and was again held constant for another five minutes.  The flow rate 
used was 1 mL per minute.  The butyryl CoA reaction was run before addition of 
MmgA, and every hour up to three hours after addition of MmgA, and an 
overnight sample was applied to the column.  Between all HPLC trials the 
reaction was incubated at 37oC.  Signals from the chromatogram were assigned 
by comparison to authentic standards. 
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